WO2023210059A1 - 有用成分包含タウリン結晶を配合した皮膚外用剤組成物 - Google Patents
有用成分包含タウリン結晶を配合した皮膚外用剤組成物 Download PDFInfo
- Publication number
- WO2023210059A1 WO2023210059A1 PCT/JP2022/047061 JP2022047061W WO2023210059A1 WO 2023210059 A1 WO2023210059 A1 WO 2023210059A1 JP 2022047061 W JP2022047061 W JP 2022047061W WO 2023210059 A1 WO2023210059 A1 WO 2023210059A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- crystals
- taurine
- mass
- ingredients
- aqueous solution
- Prior art date
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 421
- 239000013078 crystal Substances 0.000 title claims abstract description 274
- 229960003080 taurine Drugs 0.000 title claims abstract description 209
- 239000000203 mixture Substances 0.000 title claims abstract description 101
- 239000003860 topical agent Substances 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 claims abstract description 66
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 239000000126 substance Substances 0.000 claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 162
- 239000004615 ingredient Substances 0.000 claims description 88
- 238000002360 preparation method Methods 0.000 claims description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 33
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 27
- 239000000049 pigment Substances 0.000 claims description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 23
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 22
- 239000003960 organic solvent Substances 0.000 claims description 20
- 235000011187 glycerol Nutrition 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 13
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 12
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 11
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 11
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 11
- 229940105990 diglycerin Drugs 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 8
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 7
- OWTXHZITCDRRTI-UHFFFAOYSA-N 3-cyclohexyloxypropane-1,2-diol Chemical compound OCC(O)COC1CCCCC1 OWTXHZITCDRRTI-UHFFFAOYSA-N 0.000 claims description 7
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 7
- 230000017531 blood circulation Effects 0.000 claims description 7
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 7
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 claims description 7
- 235000013772 propylene glycol Nutrition 0.000 claims description 7
- 239000000419 plant extract Substances 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 230000020411 cell activation Effects 0.000 claims description 4
- 239000005515 coenzyme Substances 0.000 claims description 4
- 239000002207 metabolite Substances 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- -1 vitamin B3 compound Chemical class 0.000 description 77
- 210000003491 skin Anatomy 0.000 description 58
- 239000012071 phase Substances 0.000 description 49
- 238000003756 stirring Methods 0.000 description 29
- 239000003921 oil Substances 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 28
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 20
- 238000001914 filtration Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000000843 powder Substances 0.000 description 17
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 235000010323 ascorbic acid Nutrition 0.000 description 12
- 229960005070 ascorbic acid Drugs 0.000 description 12
- 239000011668 ascorbic acid Substances 0.000 description 12
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 235000005152 nicotinamide Nutrition 0.000 description 12
- 239000011570 nicotinamide Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 11
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 10
- 150000001298 alcohols Chemical class 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 10
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 10
- 235000019388 lanolin Nutrition 0.000 description 10
- 229940039717 lanolin Drugs 0.000 description 10
- 239000008213 purified water Substances 0.000 description 10
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 235000013793 astaxanthin Nutrition 0.000 description 8
- 239000001168 astaxanthin Substances 0.000 description 8
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 8
- 229940022405 astaxanthin Drugs 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 7
- 150000005846 sugar alcohols Polymers 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 6
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 241000218657 Picea Species 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 229960002104 cyanocobalamin Drugs 0.000 description 6
- 235000000639 cyanocobalamin Nutrition 0.000 description 6
- 239000011666 cyanocobalamin Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 235000017788 Cydonia oblonga Nutrition 0.000 description 5
- 239000004386 Erythritol Substances 0.000 description 5
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 5
- 241000209094 Oryza Species 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 5
- 229940009714 erythritol Drugs 0.000 description 5
- 235000019414 erythritol Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000000879 optical micrograph Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 229940083957 1,2-butanediol Drugs 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- 240000003538 Chamaemelum nobile Species 0.000 description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 description 4
- 240000000171 Crataegus monogyna Species 0.000 description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 4
- 244000000626 Daucus carota Species 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 108010016626 Dipeptides Proteins 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 4
- 229920000161 Locust bean gum Polymers 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 235000010420 locust bean gum Nutrition 0.000 description 4
- 239000000711 locust bean gum Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 240000001972 Gardenia jasminoides Species 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
- 229960002079 calcium pantothenate Drugs 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000013081 microcrystal Substances 0.000 description 3
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 3
- 239000001054 red pigment Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 239000001052 yellow pigment Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- VRUOTYGNKCHBJA-GRKSLAKBSA-N (2R,4R)-3-[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxypentane-1,2,4,5-tetrol Chemical compound OC[C@@H](O)C(O[C@@H]1O[C@@H]([C@H](O)CO)[C@H](O)[C@H]1O)[C@H](O)CO VRUOTYGNKCHBJA-GRKSLAKBSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 241000157282 Aesculus Species 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 240000005528 Arctium lappa Species 0.000 description 2
- 235000003130 Arctium lappa Nutrition 0.000 description 2
- 235000008078 Arctium minus Nutrition 0.000 description 2
- 241000208983 Arnica Species 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 2
- 241000131283 Cantharis Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000951471 Citrus junos Species 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 240000008632 Cota tinctoria Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- UQPHVQVXLPRNCX-GSVOUGTGSA-N D-erythrulose Chemical compound OC[C@@H](O)C(=O)CO UQPHVQVXLPRNCX-GSVOUGTGSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 2
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 2
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 241000721662 Juniperus Species 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 2
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-WVZVXSGGSA-N L-xylulose Chemical compound OC[C@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-WVZVXSGGSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241000039951 Lithocarpus glaber Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 241001529735 Melissa Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- NIBVDXPSJBYJFT-VBBCUDLLSA-N Planteose Natural products O(C[C@@H]1[C@H](O)[C@@H](O)[C@@](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)(CO)O1)[C@@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1 NIBVDXPSJBYJFT-VBBCUDLLSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 241000219492 Quercus Species 0.000 description 2
- 235000016976 Quercus macrolepis Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 241001247145 Sebastes goodei Species 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- LNRUEZIDUKQGRH-UHFFFAOYSA-N Umbelliferose Natural products OC1C(O)C(CO)OC1(CO)OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 LNRUEZIDUKQGRH-UHFFFAOYSA-N 0.000 description 2
- YUSNDFRUEQZBJG-UHFFFAOYSA-N Umbilicin Natural products OCC(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C1O YUSNDFRUEQZBJG-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FLUADVWHMHPUCG-OVEXVZGPSA-N Verbascose Natural products O(C[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](OC[C@@H]2[C@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]3(CO)[C@H](O)[C@@H](O)[C@@H](CO)O3)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 FLUADVWHMHPUCG-OVEXVZGPSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 2
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 2
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 2
- 150000001304 aldoheptoses Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 2
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HBHZKFOUIUMKHV-UHFFFAOYSA-N chembl1982121 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HBHZKFOUIUMKHV-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229910000423 chromium oxide Inorganic materials 0.000 description 2
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 2
- 229940120503 dihydroxyacetone Drugs 0.000 description 2
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 235000012732 erythrosine Nutrition 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229940108690 glucosyl hesperidin Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 235000010181 horse chestnut Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229960004337 hydroquinone Drugs 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- AEMOLEFTQBMNLQ-CLQWQSTFSA-N l-iduronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-CLQWQSTFSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- NIBVDXPSJBYJFT-ZQSKZDJDSA-N planteose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 NIBVDXPSJBYJFT-ZQSKZDJDSA-N 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- VVNRQZDDMYBBJY-UHFFFAOYSA-M sodium 1-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=CC2=C(S([O-])(=O)=O)C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C21 VVNRQZDDMYBBJY-UHFFFAOYSA-M 0.000 description 2
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 2
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000001040 synthetic pigment Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 2
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 2
- 239000002383 tung oil Substances 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 229960004747 ubidecarenone Drugs 0.000 description 2
- LNRUEZIDUKQGRH-YZUCMPLFSA-N umbelliferose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LNRUEZIDUKQGRH-YZUCMPLFSA-N 0.000 description 2
- FLUADVWHMHPUCG-SWPIJASHSA-N verbascose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)O3)O)O2)O)O1 FLUADVWHMHPUCG-SWPIJASHSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- CTUFKZFWHRPQEC-HOTGVXAUSA-N (2s)-n-[(2s)-4-amino-1-(benzylamino)-1-oxobutan-2-yl]-1-(3-aminopropanoyl)pyrrolidine-2-carboxamide Chemical compound N([C@@H](CCN)C(=O)NCC=1C=CC=CC=1)C(=O)[C@@H]1CCCN1C(=O)CCN CTUFKZFWHRPQEC-HOTGVXAUSA-N 0.000 description 1
- BVYVWYKOCOGULA-JBUMCTQMSA-N (2s,3r)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]butanoyl]amino]-3-hydroxybutanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BVYVWYKOCOGULA-JBUMCTQMSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- BNOGJEJAYILSFT-XNSRJBNMSA-N 1(F)-alpha-D-galactosylraffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1)O)CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 BNOGJEJAYILSFT-XNSRJBNMSA-N 0.000 description 1
- MZEKAHGOAYZCSP-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6-dodecamethylcyclohexane Chemical compound CC1(C)C(C)(C)C(C)(C)C(C)(C)C(C)(C)C1(C)C MZEKAHGOAYZCSP-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- CUVLMZNMSPJDON-UHFFFAOYSA-N 1-(1-butoxypropan-2-yloxy)propan-2-ol Chemical compound CCCCOCC(C)OCC(C)O CUVLMZNMSPJDON-UHFFFAOYSA-N 0.000 description 1
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- QWWTXMUURQLKOT-UHFFFAOYSA-N 1-phenoxypropan-2-yl acetate Chemical compound CC(=O)OC(C)COC1=CC=CC=C1 QWWTXMUURQLKOT-UHFFFAOYSA-N 0.000 description 1
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- FEVQEKNYIKQVIR-UHFFFAOYSA-N 2-(2-methylhexoxy)ethanol Chemical compound CCCCC(C)COCCO FEVQEKNYIKQVIR-UHFFFAOYSA-N 0.000 description 1
- NCHBYORVPVDWBJ-UHFFFAOYSA-N 2-(3-methylbutoxy)ethanol Chemical compound CC(C)CCOCCO NCHBYORVPVDWBJ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- CKGQJOFAVYEVFG-KXQOOQHDSA-N 2-fluoro-4-[[(1R)-6-[2-[4-[1-(4-methoxyphenyl)-5-methyl-6-oxopyridazin-3-yl]triazol-1-yl]ethoxy]-1-methyl-1-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,4-dihydro-2H-isoquinolin-7-yl]oxy]benzoic acid Chemical compound COc1ccc(cc1)-n1nc(cc(C)c1=O)-c1cn(CCOc2cc3CCN[C@](C)(CC(=O)Nc4nccs4)c3cc2Oc2ccc(C(O)=O)c(F)c2)nn1 CKGQJOFAVYEVFG-KXQOOQHDSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- 229940078578 2-o-ethyl ascorbic acid Drugs 0.000 description 1
- WHFKYDMBUMLWDA-UHFFFAOYSA-N 2-phenoxyethyl acetate Chemical compound CC(=O)OCCOC1=CC=CC=C1 WHFKYDMBUMLWDA-UHFFFAOYSA-N 0.000 description 1
- DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 description 1
- CUZKCNWZBXLAJX-UHFFFAOYSA-N 2-phenylmethoxyethanol Chemical compound OCCOCC1=CC=CC=C1 CUZKCNWZBXLAJX-UHFFFAOYSA-N 0.000 description 1
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QJQNWKPSKDLCOX-UHFFFAOYSA-N 3,3-diamino-2-hydroxybutanoic acid Chemical compound NC(C(C(=O)O)O)(C)N QJQNWKPSKDLCOX-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- GXRFOOHMMLYYNW-UJURSFKZSA-N 3-o-Ethyl-L-ascorbic acid Chemical compound CCOC1=C(O)[C@@H]([C@@H](O)CO)OC1=O GXRFOOHMMLYYNW-UJURSFKZSA-N 0.000 description 1
- GBSGXZBOFKJGMG-UHFFFAOYSA-N 3-propan-2-yloxypropan-1-ol Chemical compound CC(C)OCCCO GBSGXZBOFKJGMG-UHFFFAOYSA-N 0.000 description 1
- VXLKZBRLFFGAQT-UHFFFAOYSA-N 3h-benzimidazole-5-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N=CNC2=C1 VXLKZBRLFFGAQT-UHFFFAOYSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- ATSBFAGKFWTGFG-UWVGGRQHSA-N 5'-(N(6)-L-lysine)-L-tyrosylquinone Chemical compound OC(=O)[C@@H](N)CCCCNC1=CC(=O)C(=O)C=C1C[C@H](N)C(O)=O ATSBFAGKFWTGFG-UWVGGRQHSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- XVNQDRSYPPDDQF-UHFFFAOYSA-N 7-[2-(2,5,6,7-tetrasulfo-3h-benzimidazol-4-yl)phenyl]-1h-benzimidazole-2,4,5,6-tetrasulfonic acid Chemical compound OS(=O)(=O)C1=C(S(O)(=O)=O)C(S(O)(=O)=O)=C2NC(S(=O)(=O)O)=NC2=C1C1=CC=CC=C1C1=C(S(O)(=O)=O)C(S(O)(=O)=O)=C(S(O)(=O)=O)C2=C1N=C(S(O)(=O)=O)N2 XVNQDRSYPPDDQF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 241001646648 Aesculus turbinata Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000010893 Bischofia javanica Nutrition 0.000 description 1
- 240000005220 Bischofia javanica Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241001661792 Buddleja axillaris Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000233838 Commelina Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-JFNONXLTSA-N L-mannopyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-JFNONXLTSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- AGMJSPIGDFKRRO-YFKPBYRVSA-N L-topaquinone Chemical compound OC(=O)[C@@H](N)CC1=CC(=O)C(O)=CC1=O AGMJSPIGDFKRRO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- OSEGOMJCJRKRPD-UHFFFAOYSA-N Lychnose Natural products OCC1OC(O)C(OCC2(OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)OC(CO)C(O)C2O)C(O)C1O OSEGOMJCJRKRPD-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 240000009120 Phyllanthus emblica Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- CITHMWNQCVRPGG-UHFFFAOYSA-N [Na].[Na].[Na].NCCN Chemical compound [Na].[Na].[Na].NCCN CITHMWNQCVRPGG-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- QYBNLKMPMPDFHE-UHFFFAOYSA-N acetyl hexanoate Chemical compound CCCCCC(=O)OC(C)=O QYBNLKMPMPDFHE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- GZCGUPFRVQAUEE-BXKVDMCESA-N aldehydo-L-mannose Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-BXKVDMCESA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- UGDWJDYCTNYZEU-UHFFFAOYSA-N butanedioic acid;ethane-1,2-diol Chemical compound OCCO.OC(=O)CCC(O)=O.OC(=O)CCC(O)=O UGDWJDYCTNYZEU-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 150000008266 deoxy sugars Chemical class 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- SILCDLWESNHZKB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].OC(=O)CCC([O-])=O.OC(=O)CCC([O-])=O SILCDLWESNHZKB-UHFFFAOYSA-L 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- MIEBBHYETAOCSS-UHFFFAOYSA-N octan-2-yl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(C)CCCCCC MIEBBHYETAOCSS-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 150000003227 pyridoxines Chemical class 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 1
- 239000011678 thiamine pyrophosphate Substances 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- JLGLQAWTXXGVEM-UHFFFAOYSA-N triethylene glycol monomethyl ether Chemical compound COCCOCCOCCO JLGLQAWTXXGVEM-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
Definitions
- the present invention relates to an external skin preparation composition containing taurine crystals containing useful ingredients.
- This article relates to technology for incorporating useful components during taurine recrystallization.
- Taurine is a compound with the chemical name 2-aminoethanesulfonic acid, and is the sulfur-containing free amino acid that is most abundant in living cells. Taurine is different from the amino acids that make up proteins, and is known to exhibit actions similar to vitamins and hormones, as well as various pharmacological actions, including on the brain and nervous system, circulatory system, and hepatobiliary system. However, in recent years, it has been found that it plays an important role in the moisturizing properties of the skin.
- Patent Document 1 describes a manufacturing method for obtaining taurine with high purity
- Patent Document 2 describes a manufacturing method for obtaining taurine in high yield.
- Patent Document 3 discloses that a solution containing taurine and an inorganic salt is brought into contact with a porous solid material that exhibits a molecular sieving effect, and taurine is adsorbed onto the porous solid material to form an inorganic salt.
- a method for purifying taurine is described which involves separating it from the salt and then desorbing the taurine adsorbed on the porous solid material using an organic solvent that may contain water.
- a technique of performing crystallization by adding alcohol is conventionally known.
- Patent Document 4 describes a method for purifying taurine in which impurities are separated or removed by adding alcohol to a taurine-containing reaction solution obtained through a manufacturing process.
- Patent Document 5 describes that after separating the crystals precipitated by crystallization from the mother liquor of crystallization, the crystals are treated with an alcohol aqueous solution containing hydrochloric acid, and subsequently, the crystals are treated with an alcohol aqueous solution containing hydrochloric acid.
- a method for purifying taurine using an aqueous alcohol solution is described.
- Patent Document 6 shows that when calcium pantothenate and ascorbic acid are crystallized and mixed together, stability is improved compared to when calcium pantothenate is mixed with non-crystallized calcium pantothenate. .
- Patent Document 7 describes a method of obtaining a stable liquid preparation by adding water-soluble vitamins in a crystalline state to an edible oil such as sunflower oil, corn oil, or cottonseed oil.
- Patent Document 8 describes a lipstick composition containing a crystalline vitamin B3 compound.
- composition used in this technique may be a powder mixture in the absence of water, or a composition present in a dispersed state in oil. Therefore, its use was limited to non-aqueous systems. If useful organic compounds, peptides, pigments, etc. can be stably contained in water-soluble crystals, it will be possible to color the crystals and stably incorporate useful ingredients into various formulations. Become.
- An object of the present invention is to provide a new means for intradermal delivery of useful ingredients.
- a composition for external use on the skin characterized by containing fine needle-like crystals of taurine containing useful ingredients in the crystals.
- the skin external preparation composition according to [1] which contains at least a portion of the fine needle-like crystals of taurine dispersed therein.
- the skin external preparation composition according to [1] or [2] which has a space in the fine needle-like crystals of taurine, and a useful ingredient is encapsulated in the space.
- the skin external preparation composition according to [3] wherein the spatial volume of the taurine fine needle-like crystals occupies 0.001% to 30% of the taurine crystal volume.
- the skin external preparation composition according to any one of [1] to [4], wherein the fine acicular crystals of taurine have a thickness of 150 micrometers or less and a length of 3000 micrometers or less.
- the useful ingredients include vitamins and vitamin derivatives, hydroquinone and its derivatives, whitening ingredients, anti-inflammatory ingredients, antioxidant ingredients, blood circulation promoting ingredients, cell activation ingredients, coenzymes and their intermediate metabolites, sugars, and plant extracts.
- Composition [8] The skin external preparation composition according to any one of [1] to [7], further comprising a useful ingredient dissolved or dispersed in the skin external preparation composition medium.
- a method for producing fine acicular crystals of taurine [10] The manufacturing method according to [9], wherein the liquid substance (B) is a water-soluble organic solvent.
- the water-soluble organic solvent is ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, isoprene glycol, diethylene glycol , dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, and n-hexylglycerin.
- a method for producing a skin external preparation composition containing fine needle-like crystals of taurine containing useful ingredients in the crystals comprising the following steps: A step of growing crystals in an environment where an aqueous solution (A) in which taurine is dissolved is mixed with or brought into contact with a liquid substance (B) in which taurine has a low solubility.
- the useful ingredient is included in the crystal as the crystal grows, and a step of blending fine needle-like crystals of taurine containing useful ingredients in the crystals obtained in the crystal growth step into a skin external preparation composition; manufacturing methods, including [16] The production method according to [15], wherein the concentration of the useful component in the aqueous solution (A) or the liquid substance (B) is 0.001% by mass or more. [17] The production method according to [15] or [16], wherein the concentration of taurine in the aqueous solution (A) is 3 to 28% by mass.
- the liquid substance (B) is a water-soluble organic solvent, and the water-soluble organic solvent is ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2- From the group consisting of butanediol, 1,3-butanediol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, and n-hexylglycerin
- the skin external preparation composition of the present invention contains taurine fine needle-like crystals containing useful ingredients, it is possible to stably retain the useful ingredients in the composition.
- the taurine crystals used in the present invention are recrystallized to form fine needle-shaped crystals, so when used, the crystals are pierced into the stratum corneum and the useful ingredients are directly delivered into the skin without feeling the rough texture of the crystals. Afterwards, the crystals dissolve in the moisture inside the skin, making it possible to supply the contained ingredients into the skin.
- FIG. 1 is an X-ray diffraction pattern of fine needle-like taurine crystals obtained in Example 14.
- the upper graph is astaxanthin-containing taurine fine needle crystals, and the lower graph is taurine fine needle crystals.
- FIG. 2 is an optical micrograph of fine acicular crystals of taurine obtained in Example 3.
- FIG. 3 is an optical micrograph of raw material taurine crystals.
- FIG. 4 is an optical micrograph (50x magnification) of taurine fine needle-like crystals obtained in Example 17.
- FIG. 5 is a micrograph (under fluorescence, magnification: 50x) of the taurine fine needle-like crystals obtained in Example 17.
- FIG. 6 is an optical micrograph (200x magnification) of the taurine fine needle-like crystals obtained in Example 17.
- FIG. 7 is a micrograph (under fluorescence, magnification: 200 times) of the taurine fine needle-like crystals obtained in Example 17.
- FIG. 8 is a fluorescent photograph (50x magnification) of a cross section of the skin 5 minutes after application.
- FIG. 9 is a fluorescent photograph (50x magnification) of a cross section of the skin 30 minutes after application.
- FIG. 10 is a graph showing the measurement results of Example 19 and Comparative Example 7.
- the skin external preparation composition according to the present invention contains fine needle-like crystals of taurine containing useful ingredients in the crystals.
- the skin external preparation composition preferably contains at least a portion of the fine needle-like crystals of taurine dispersed therein.
- the fine needle-like crystals of taurine can be produced by mixing an aqueous solution (A) in which taurine is dissolved with a liquid substance (B) in which taurine has a low solubility (for example, a water-soluble organic solvent), or by mixing an aqueous solution in which taurine is dissolved (A) and a liquid substance (B) in which taurine has low solubility (for example, a water-soluble organic solvent) are brought into contact (for example, an interface is formed by gently pouring the liquid substance (B) into an aqueous solution (A)) It is possible to produce taurine by creating a state in which taurine has extremely low solubility, and proceeding with recrystallization (crystal growth) there.
- the resulting fine acicular crystals of taurine have a controlled crystal shape. Further, when manufacturing the crystal, a hollow portion is formed in the fine needle-like crystals of taurine, and this hollow portion is defined as the spatial volume. Therefore, the fine needle-like crystals of taurine have spaces within the fine needle-like crystals of taurine.
- the space volume of the taurine fine needle-like crystals preferably occupies 0.001% to 30%, more preferably 0.1% to 30%, of the taurine crystal volume.
- the size of the spatial volume of the taurine fine needle-like crystals is calculated by analyzing a microscopic photograph of the crystals.
- the taurine fine needle crystals containing useful components in the crystals are added to the aqueous solution (A) or liquid substance (B) during the recrystallization of taurine. or pigment, etc.) can be manufactured by dissolving or dispersing them. It can be produced by incorporating or supporting useful components during recrystallization.
- inclusion refers to at least one of entering into the taurine crystal lattice and containing a useful component in the hollow part (space) of the taurine crystal. In the former case, the lattice constant increases as the taurine crystal expands. In the latter, the lattice constants are not broadened by inclusion.
- "Supported" means adsorbed or bonded to the surface of taurine crystals.
- taurine fine needle crystals containing or supporting a useful ingredient that is, taurine fine needle crystals containing a useful ingredient in the crystal
- useful ingredient-containing taurine fine needle crystals are referred to as useful ingredient-containing taurine fine needle crystals.
- the fine acicular crystals of taurine have spaces, and the useful ingredients are contained in the spaces.
- the raw material taurine used in the present invention is not particularly limited as long as it has been conventionally used in pharmaceuticals, quasi-drugs, and cosmetics, and may be either synthetic products or extracts from natural products.
- the fine crystals of taurine in the present invention are needle-shaped crystals, but may also be columnar crystals.
- the term "acicular crystal” refers to a shape in which the major axis of the crystal is three times or more the minor axis
- the term columnar crystal refers to a shape in which the major axis of the crystal is less than three times the minor axis.
- the fine needle-like or columnar crystals of taurine in the present invention have a crystal form that can be distinguished from the bulk crystals of raw material taurine by microscopic observation.
- the size of the taurine fine needle-like crystals is such that the thickness is 150 micrometers or less and the length is 150 micrometers or less, from the viewpoint of not leaving a rough feeling when used in a skin external preparation composition and giving a smooth application feeling.
- the thickness is preferably 3000 micrometers or less, the thickness is 5 to 150 micrometers, and the length is more preferably 100 to 3000 micrometers, the thickness is 10 to 100 micrometers, and the length is 100 to 100 micrometers.
- the thickness is 2000 micrometers, and most preferably the thickness is 10 to 60 micrometers, and the length is 150 to 2000 micrometers.
- the thickness is the short axis of the crystal, and the length is the long axis of the crystal.
- the thickness and length of the crystal can be measured using a digital microscope (for example, "Digital Microscope VHX-7000" manufactured by Keyence Corporation). Crystal forms with a thickness of more than 150 micrometers and a length of more than 3000 micrometers (for example, taurine crystals and taurine crystalline powder, which are commercially available as raw materials) may cause a rough foreign body sensation on the skin when applied. It is not desirable because it remains.
- the fine acicular crystals of taurine may include fine particle crystals with a thickness of less than 5 micrometers or a length of less than 100 micrometers, but particularly, a diameter of 150 micrometers. It is desirable not to contain crystals exceeding .
- recrystallization conditions can be set so that needle-like crystals with a thickness exceeding 150 micrometers are not generated.
- the specific recrystallization (crystal growth) conditions are a process of growing crystals in an environment where an aqueous solution in which taurine is dissolved (A) is mixed with or brought into contact with a liquid substance (B) in which taurine has a low solubility. .
- liquid substance (B) in which taurine has low solubility used for recrystallization (crystal growth) examples include organic solvents, including but not limited to acetone, methyl ethyl ketone, dimethyl sulfoxide, dimethyl formamide, and ethyl acetate. , isopropyl myristate, methylheptyl laurate and jojoba oil; non-polar organic solvents such as dodecane, isododecane, liquid paraffin, squalane, hydrogenated polyisobutene and olefin oligomers; alcohols such as ethanol and 1-propanol.
- organic solvents including but not limited to acetone, methyl ethyl ketone, dimethyl sulfoxide, dimethyl formamide, and ethyl acetate.
- isopropyl myristate, methylheptyl laurate and jojoba oil non-polar organic solvents such as dodecane, is
- the liquid substance (B) is preferably a liquid substance (water-soluble organic solvent) having a solubility in water at 25°C of 1% by mass or more, since addition has a high effect of lowering the solubility of taurine.
- ethanol 1-propanol, 2-propanol, 1-butanol, 2-butanol, ethylene glycol, diethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol, 1, 3-butanediol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, acetone, methyl ethyl ketone, dimethyl sulfoxide, dimethyl formamide, cyclohexylglycerin, or n-hexyl Glycerin is preferred.
- the liquid substance (B) includes ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1, 2-butanediol, 1,3-butanediol, isoprene glycol, diethylene glycol, dipropylene glycol, glycerin, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, or n-hexylglycerin. is most preferable.
- One type of these solvents can be used, or a mixed solvent of two or more types can be used.
- the crystal form will not be fine needle-like crystals, resulting in a rough texture when used in an external skin preparation composition, which is not preferable.
- the concentration of taurine in the aqueous solution (A) in which taurine is dissolved used for recrystallization is preferably 3% by mass or more from the viewpoint of forming fine needle-like crystals when mixed with a solvent in which taurine has low solubility. From the viewpoint of the solubility of taurine in water, it is preferably 28% by mass or less. If it is less than 3% by mass, crystals will not precipitate unless the liquid substance (B) is added to the aqueous solution (A) in an amount of 100% by mass or more, and a sufficient amount of crystals will not be obtained, resulting in poor cost and yield. And it's not realistic. If it exceeds 28% by mass, it becomes difficult to dissolve taurine even when heated to 80° C.
- the concentration of taurine in the aqueous solution (A) in which taurine is dissolved is preferably 5 to 20% by mass, more preferably 6 to 18% by mass, and preferably 7 to 15% by mass. is most preferred.
- aqueous solution (A) in which taurine used for recrystallization is dissolved one or more water-soluble organic solvents in which taurine has low solubility are added as a liquid substance (B) for the purpose of reducing the saturation concentration. It is possible to do so.
- water-soluble organic solvents include glycerin, 1,3-propanediol, ethanol, isopropyl alcohol, ethylene glycol, 1,2-propanediol, 1,2-butanediol, 1,3-butanediol, isoprene glycol , diethylene glycol, dipropylene glycol, diglycerin, 1,2-pentanediol, 1,2-hexanediol, cyclohexylglycerin, n-hexylglycerin and the like are preferred.
- the concentration of the liquid substance (B) is preferably 50% by mass or less, more preferably 30% by mass or less, and most preferably 25% by mass or less, based on the total amount of the aqueous solution (A). If it exceeds 50% by mass, the solubility of taurine becomes too low and a sufficient amount of crystals cannot be obtained, which is not practical in terms of cost and yield.
- the useful components included in the fine needle-like crystals of taurine are not particularly limited.
- the above-mentioned useful ingredients include vitamins and vitamin derivatives, hydroquinone and its derivatives, whitening ingredients, anti-inflammatory ingredients, antioxidant ingredients, blood circulation promoting ingredients, cell activation ingredients, coenzymes and their intermediate metabolites, sugars, plant extract ingredients, Examples include peptides, proteins, and dyes.
- the vitamins and vitamin derivatives, hydroquinone and its derivatives, whitening ingredients, anti-inflammatory ingredients, antioxidant ingredients, blood circulation promoting ingredients, cell activation ingredients, coenzymes and their intermediate metabolites include, for example, nicotinamide, glycyrrhizinate.
- tranexamic acid L-ascorbic acid-2-glucoside, sodium ascorbyl phosphate, glyceryl ascorbic acid, bisglyceryl ascorbic acid, 3-glyceryl ascorbic acid, hexyl 3-glyceryl ascorbic acid, myristyl 3-glyceryl ascorbic acid, 3-lauryl Glyceryl ascorbic acid, arbutin, kojic acid, allantoin, cyanocobalamin, riboflavin, pyridoxine salt, glucosylhesperidin, ascorbyl tetrahexyldecanoate, 3-O-ethyl ascorbic acid, tocopherol acetate, sodium copper chlorophyllin, folic acid, hydroquinone, ubiquinone, pyrroloquinoline quinone , topaquinone, tryptophan-tryptophyllquinone, lysine tyrosylquinone, cyst
- the saccharides include D-glycerylaldehyde, dihydroxyacetone, D-erythrose, D-erythrulose, D-threose, erythritol, L-arabinose, D-xylose, L-lyxose, D-arabinose, D-ribose, D-ribulose, D-xylulose, L-xylulose, D-glucose, D-talose, D-busicose, D- Galactose, D-fructose, L-galactose, L-mannose, D-tagatose, aldoheptose, heprose, octulose, etc., 2-deoxy-D-ribose , 6-deoxy-L-galactose, 6-deoxy-L-mannose, D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, muramic acid, etc.
- the plant extract components include, for example, Panax ginseng, Ashitaba, arnica, ginkgo, fennel, turmeric, dayflower, Dutch oak, chamomile, Roman chamomile, carrot, gentian, burdock, rice, hawthorn, shiitake, ginger, hawthorn, juniper, Japanese nebula, Japanese assembly, thyme, clove, chimpi, chili pepper, chimpanzee, spruce, carrot, garlic, butcher bloom, grape, button, horse chestnut, melissa, yuzu, Japanese horse chestnut, ryokucha, rosemary, rosehip, chimpi, spruce, spruce , peach, apricot, walnut, corn, golden chamomile, ictamol, cantharis tincture, and cephalanthine.
- Panax ginseng Ashitaba, arnica, ginkgo, fennel, turmeric, dayflower, Dutch oak, cham
- the peptides include (arginine/lysine) polypeptide, 3-ascorbyl carbonyl dipeptide, acetylcyclohexapeptide, acetyltetrapeptide, acetyltetrapeptide, acetyltetrapeptide, acetyltetrapeptide, acetyltetrapeptide, acetylhexapeptide, acetylhexapeptide, acetylheptapeptide.
- Peptide acetyl pentapeptide, oligopeptide, caffeoyl tripeptide, capryloyl dipeptide, capryloyl synthetic human nonapeptide, dipeptide, diacetate dipeptide diaminobutyroylbenzylamide, decapeptide, tetrapeptide, trifluoroacetyl tripeptide, tripeptide, Tripeptide-1 copper, nonapeptide, palmitic acid heptapeptide, palmitoyl octapeptide, palmitoyl oligopeptide, palmitoyl dipeptide, palmitoyl dipeptide-5 diaminohydroxybutyric acid, palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine, palmitoyl tetrapeptide, human genetic recombination
- the proteins include almond protein, rice protein, wheat protein, wheat germ protein, soybean protein, corn gluten protein, and nacre protein.
- the pigments include natural pigments and synthetic pigments, and the natural pigments include, for example, gardenia yellow pigment, safflower yellow pigment, turmeric pigment, moss mallow yellow pigment, marigold pigment, moss colp pigment, gardenia red pigment, and safflower red pigment. , tomato pigment, cochineal pigment, perilla pigment, red cabbage pigment, red radish pigment, purple sweet potato pigment, grape skin pigment, cacao pigment, caramel pigment, gardenia blue pigment, etc.
- Examples of synthetic pigments include Red No. 201, Red Organics such as No. 202, Red No. 204, Red No. 205, Red No.
- the above-mentioned useful components are not limited to water-soluble components, but may also be oil-soluble components.
- ingredients that are easily oxidized especially ingredients that could not previously be blended due to odor or discoloration over time, can be incorporated stably by being encapsulated in taurine fine needle crystals. It is.
- the fine needle-like crystals of taurine in the skin external preparation composition dissolve after the skin external preparation composition is applied to the skin, so that the contained ingredients are dissolved into the skin in a fresh state. Can be applied.
- bio-derived components such as polymer polysaccharides, peptides such as growth factors, and proteins that are difficult to penetrate the skin can be included in the taurine crystals, and the needle-shaped taurine crystals in the composition can be directly inserted into the skin to penetrate the skin.
- the amount of the useful component included can be expressed as the inclusion ratio, which is the amount of the useful component included in the weight of the entire crystal.
- the inclusion rate of the useful component in the taurine fine needle crystals is preferably 0.001 to 30% by mass, more preferably 0.001 to 25% by mass, and 0.001 to 20% by mass. % is most preferred. If the amount is less than 0.001% by mass, the effects of the included useful components cannot be sufficiently obtained, which is not preferable.
- the above-mentioned useful component is an aqueous solution (A) in which taurine is dissolved or an aqueous solution (A) in which taurine has a low solubility. It is preferable to use it dissolved or dispersed in the liquid substance (B).
- the concentration of the useful component is preferably 0.001% by mass or more in the aqueous solution (A) or liquid substance (B) from the viewpoint of the amount of the encapsulated component incorporated into the taurine crystal. If it is less than 0.001% by mass, it is not possible to confirm that the encapsulated component is contained, which is not preferable.
- the upper limit of the concentration of the above-mentioned useful components is not particularly limited.
- the fine needle-like crystals of taurine containing useful ingredients in the crystals may be filtered and dried and then added to the skin external preparation composition, or the solution in which the crystals are precipitated may be added as is.
- the useful ingredients are not only present in the fine needle-like crystals of taurine, but may also be dissolved or dispersed in the medium of the skin external preparation composition. In that case, the useful component in the fine needle-like crystals of taurine and the useful component dissolved or dispersed in the medium of the skin external preparation composition may be the same or different.
- the skin external composition of the present invention can be used mainly as a skin external composition for cosmetics or quasi-drugs.
- the dosage form of the skin external composition of the present invention is not particularly limited, but examples thereof include solutions, lotions, cosmetic oils, emulsions, creams, aqueous gels, ointments, and the like. These formulations can be prepared by conventional methods.
- the skin external preparation composition of the present invention may include ingredients normally used in preparations such as cosmetics, quasi-drugs, and external medicines, such as water, oil, etc., to the extent that the effects of the present invention are not impaired.
- One or more types can be added as appropriate.
- the water contained in the skin external preparation composition of the present invention is not particularly limited, and examples thereof include purified water, ion exchange water, tap water, and the like.
- water-soluble alcohols include lower alcohols, polyhydric alcohols, polyhydric alcohol polymers, dihydric alcohol alkyl ethers, dihydric alcohol alkyl ethers, dihydric alcohol ether esters, glycerin monoalkyl ethers, sugar alcohols, Examples include monosaccharides, oligosaccharides, polysaccharides, and derivatives thereof.
- lower alcohols examples include ethanol, propanol, isopropanol, isobutyl alcohol, and t-butyl alcohol.
- polyhydric alcohols examples include dihydric alcohols (e.g., dipropylene glycol, 1,3-butylene glycol, ethylene glycol, trimethylene glycol, 1,2-butylene glycol, tetramethylene glycol, 2,3-butylene glycol, pentamethylene glycol, 2-butene-1,4-diol, hexylene glycol, octylene glycol, etc.), trihydric alcohols (e.g., glycerin, trimethylolpropane, etc.), tetrahydric alcohols (e.g., diglycerin, 1,2 , 6-hexanetriol, pentaerythritol, etc.), pentahydric alcohols (e.g., xylitol, triglycerin, etc.), hexahydric alcohols (e.g., sorbitol, mannitol, etc.), polyhydric alcohol polymers (e.g., diethylene
- maltotriose mannitol, sucrose, erythritol, glucose, fructose, starch-degrading sugar, maltose, starch-degrading sugar, reduced alcohol, etc.
- glycolide tetrahydrofurfuryl alcohol, POE-tetrahydrofuryl Furyl alcohol, POP-butyl ether, POP/POE-butyl ether tripolyoxypropylene glycerin ether, POP-glycerin ether, POP-glycerin ether phosphoric acid, POP/POE-pentane erythritol ether, polyglycerin, and the like.
- monosaccharides include tricarbon sugars (e.g., D-glycerylaldehyde, dihydroxyacetone, etc.), tetracarbonses (e.g., D-erythrose, D-erythrulose, D-threose, erythritol, etc.), Pentose (e.g.
- oligosaccharide examples include sucrose, gunthianose, umbelliferose, lactose, planteose, isorychnose, ⁇ , ⁇ -trehalose, raffinose, lichnose, umbilicin, stachyose verbascose, and the like.
- polysaccharides include cellulose, quince seed, starch, galactan, dermatan sulfate, glycogen, gum arabic, heparan sulfate-tragacanth gum, keratan sulfate, chondroitin, xanthan gum, guar gum, dextran, keratosulfate, locust bean gum, succinoglucan, etc. can be mentioned.
- anti-inflammatory agents include components derived from plants, allantoin and its derivatives, glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its salts or derivatives, salicylic acid derivatives, aminocaproic acid, azulene and its derivatives, and the like.
- gelling agents examples include gum arabic, carrageenan, gum colora, gum tragacanth, carob gum, quince seed (quince), casein, dextrin, gelatin, sodium pectate, sodium araginate, methylcellulose, ethylcellulose, CMC, Hydroxyethylcellulose, hydroxypropylcellulose, PVA, PVM, PVP, sodium polyacrylate, carboxyvinyl polymer, locust bean gum, guar gum, tamarind gum, dialkyldimethylammonium cellulose sulfate, xanthan gum, magnesium aluminum silicate, bentonite, hectorite, silicic acid Examples include A1Mg (vegum), laponite, and silicic anhydride.
- natural water-soluble polymers include plant-based polymers (e.g., gum arabic, gum tragacanth, galactan, guar gum, carob gum, gum caraya, carrageenan, pectin, agar, quince seed (quince), algae colloid (cassava extract), starch). (rice, corn, potato, wheat), glycyrrhizic acid), microbial polymers (e.g. xanthan gum, dextran, succinoglucan, pullulan, etc.), animal polymers (e.g. collagen, casein, albumin, gelatin, etc.), etc. can be mentioned.
- plant-based polymers e.g., gum arabic, gum tragacanth, galactan, guar gum, carob gum, gum caraya, carrageenan, pectin, agar, quince seed (quince), algae colloid (cassava extract), starch).
- plant-based polymers e.g., gum arabic, gum
- semi-synthetic water-soluble polymers include starch-based polymers (e.g., carboxymethyl starch, methylhydroxypropyl starch, etc.), cellulose-based polymers (methyl cellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, sodium cellulose sulfate) , hydroxypropylcellulose, carboxymethylcellulose, sodium carboxymethylcellulose, crystalline cellulose, cellulose powder, etc.), alginic acid-based polymers (eg, sodium alginate, propylene glycol alginate, etc.), and the like.
- starch-based polymers e.g., carboxymethyl starch, methylhydroxypropyl starch, etc.
- cellulose-based polymers methyl cellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, sodium cellulose sulfate
- hydroxypropylcellulose carboxymethylcellulose, sodium carboxymethylcellulose,
- Examples of synthetic water-soluble polymers include vinyl polymers (e.g., polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, carboxyvinyl polymer, etc.), polyoxyethylene polymers (e.g., polyethylene glycol 20,000, 40 ,000, 60,000, etc.), acrylic polymers (eg, sodium polyacrylate, polyethyl acrylate, polyacrylamide, etc.), polyethyleneimine, cationic polymers, and the like.
- vinyl polymers e.g., polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, carboxyvinyl polymer, etc.
- polyoxyethylene polymers e.g., polyethylene glycol 20,000, 40 ,000, 60,000, etc.
- acrylic polymers eg, sodium polyacrylate, polyethyl acrylate, polyacrylamide, etc.
- polyethyleneimine cationic polymers
- humectants include chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salts, DL-pyrrolidone carboxylate, short chain soluble collagen, Examples include diglycerin (EO) PO adduct, Izayo thorn extract, Yarrow extract, Melilot extract, and the like.
- EO diglycerin
- whitening agents examples include vitamin C such as tranexamic acid, ascorbic acid and its salts, and ascorbic acid derivatives (sodium ascorbic acid phosphate, magnesium ascorbic acid phosphate, ascorbyl tetra-2-hexyldecanoate, (2-O-ethyl ascorbic acid, 3-O-ethyl ascorbic acid, ascorbic acid glucoside, etc.), arbutin, kojic acid, placenta, ellagic acid, nicotinamide, hydroquinone, linoleic acid and its derivatives.
- vitamin C such as tranexamic acid, ascorbic acid and its salts
- ascorbic acid derivatives sodium ascorbic acid phosphate, magnesium ascorbic acid phosphate, ascorbyl tetra-2-hexyldecanoate, (2-O-ethyl ascorbic acid, 3-O-ethyl ascorbic acid, ascorbic acid glucoside,
- keratolytic agents include lactic acid, salicylic acid, gluconic acid, glycolic acid, citric acid, malic acid, fruit acid, phytic acid, urea, and sulfur.
- Anti-aging ingredients include, for example, hydrolyzed soy protein, retinoids (retinol and its derivatives, retinoic acid, retinal, etc.), kinetin, adenosine, NMN (nicotinamide mononucleotide), AMP (adenosine monophosphate), ADP ( Examples include adenosine diphosphate), ATP (adenosine triphosphate), ursolic acid, turmeric extract, sphingosine derivatives, mevalonolactone, and the like.
- anti-glycation agents examples include plant extracts such as Buddleja axillaris leaf extract, evening primrose oil, amla fruit, fruit juice or extracts thereof, L-arginine, L-lysine, hydrolyzed casein, Examples include hydrolyzable tannins and carnosine.
- blood circulation promoters blood circulation promoting ingredients
- blood circulation promoting ingredients include Panax ginseng, Angelica oleracea, arnica, ginkgo, fennel, chiliflower, Dutch oak, chamomile, Roman chamomile, carrot, gentian, burdock, rice, hawthorn, shiitake, ginger, and hawthorn.
- polyphenols examples include flavonoid polyphenols such as curcuminoids, flavanones, stilpenoids, polymethoxyflavonoids, flavonols, xanthonoids, chalcone, lignoids, flavanols, and isoflavones.
- flavonoid polyphenols such as curcuminoids, flavanones, stilpenoids, polymethoxyflavonoids, flavonols, xanthonoids, chalcone, lignoids, flavanols, and isoflavones.
- metal ion sequestering agent examples include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, edetate disodium, edetate trisodium, and edetate tetrasodium. , sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid, trisodium ethylenediamine hydroxyethyl triacetate, and the like.
- ultraviolet protective agents water-soluble ultraviolet absorbers
- examples of ultraviolet protective agents include 2,4-dihydroxybenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone, 2, 2',4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, Benzophenone UV absorbers such as 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone, phenyl Benzimidazole-based ultraviolet absorbers such as benzimidazole-5-sulfonic acid and its salts, phenylene-bis-benzimidazole-tetra
- powders include inorganic powders (such as talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, rhodochite, biotite, permiculite, magnesium carbonate, carbonate Calcium, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (calcined gypsum), calcium phosphate, fluoroapatite, hydroxy apatite, ceramic powder, metal soap (e.g.
- inorganic powders such as talc, kaolin, mica, sericite, muscovite, phlogopite, synthetic mica, rhodochite, biotite, permiculite, magnesium carbonate, carbonate Calcium, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate
- organic powder e.g. polyamide resin powder (nylon powder), polyethylene powder, polymethyl methacrylate powder, polystyrene powder, styrene and acrylic acid copolymer resin powder, benzoguanamine resin powder, polytetrafluoroethylene powder, cellulose powder, etc.
- inorganic white pigments e.g. titanium dioxide, zinc oxide, etc.
- inorganic red pigments e.g.
- iron oxide red iron oxide, iron titanate, etc.
- inorganic brown pigments e.g., ⁇ -iron oxide, etc.
- inorganic yellow pigments e.g., yellow iron oxide, ocher, etc.
- inorganic black pigments e.g., black iron oxide, lower titanium oxide, etc.
- inorganic purple pigments e.g., mango violet, cobalt violet, etc.
- inorganic green pigments e.g., chromium oxide, chromium hydroxide, cobalt titanate, etc.
- inorganic blue pigments e.g., chromium oxide, chromium hydroxide, cobalt titanate, etc.
- ultramarine, navy blue, etc. pearl pigments (for example, titanium oxide coated mica, titanium oxide coated bismuth oxychloride, titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil, etc.), metal powder pigments ( (e.g., aluminum
- natural pigments e.g., chlorophyll, ⁇ -carotene
- vitamins examples include vitamins A, B1, B2, B6, C, E and their derivatives, pantothenic acid and its derivatives, biotin, and the like.
- antioxidants examples include tocopherols, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters, and the like.
- pH adjuster examples include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
- oil phase component examples include liquid oils and fats, solid oils, waxes, hydrocarbon oils, higher fatty acids, synthetic ester oils, silicone oils, etc. that are commonly used in cosmetics and quasi-drugs.
- oil phase components and the aqueous phase components described above can be combined with a suitable surfactant to form a skin composition.
- liquid oils examples include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, and linseed oil. , safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, Japanese tung oil, Japanese tung oil, jojoba oil, germ oil, triglycerin, and the like.
- solid fats and oils examples include cacao butter, coconut oil, horse tallow, hydrogenated coconut oil, palm oil, beef tallow, mutton tallow, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, Japanese oak kernel oil, hydrogenated oil, and beef tallow.
- examples include leg fat, Japanese oak oil, and hydrogenated castor oil.
- waxes examples include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, privet wax, spermaceti wax, montan wax, bran wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, isopropyl lanolin fatty acid, hexyl laurate, and reduced lanolin.
- Jojoba wax, hard lanolin, shellac wax polyoxyethylene lanolin alcohol ether, polyoxyethylene lanolin alcohol acetate, polyoxyethylene cholesterol ether, lanolin fatty acid polyethylene glycol, polyoxyethylene hydrogenated lanolin alcohol ether, cetyl palmitate, etc.
- hydrocarbon oil examples include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, and the like.
- higher fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tolic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), etc. can be mentioned.
- Examples of the synthetic ester oil include cetyl octoate, myristyl myristate, glyceryl tri-2-ethylhexanoate, pentaerythritol tetra-2-ethylhexanoate, dioctyl succinate, tripropylene glycol dineopentanoate, and the like.
- silicone oils include linear polysiloxanes (e.g., dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (e.g., octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexane, etc.); sasiloxane, etc.), silicone resins forming three-dimensional network structures, silicone rubber, various modified polysiloxanes (amino-modified polysiloxanes, polyether-modified polysiloxanes, alkyl-modified polysiloxanes, fluorine-modified polysiloxanes, etc.), acrylic silicones etc.
- linear polysiloxanes e.g., dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxan
- Amino acids include neutral amino acids glycine, alanine, valine, leucine, isoleucine, aliphatic amino acids, oxyamino acids serine, threonine, aliphatic amino acids, and sulfur-containing amino acids cysteine, cystine, and methionine. , acidic amino acids glutamic acid and aspartic acid, amide group-containing amino acids glutamine and asparagine, basic amino acids arginine, aromatic amino acids phenylalanine and tyrosine, and imino group-containing proline and oxyproline.
- the method for producing the skin external preparation composition of the present invention is characterized by including the following steps: A step of growing crystals in an environment where an aqueous solution (A) in which taurine is dissolved is mixed with or brought into contact with a liquid substance (B) in which taurine has a low solubility. B) By dissolving or dispersing the useful ingredient in the crystal, the useful ingredient is included in the crystal as the crystal grows, and A step of blending fine needle-shaped taurine crystals containing useful ingredients in the crystals obtained in the crystal growth step into a skin external preparation composition.
- individual skin external preparation compositions can be prepared while preserving the taurine fine needle-shaped crystals containing the useful ingredient, or can be recrystallized separately. It can be prepared by blending filtered and dried taurine fine needle-like crystals containing useful ingredients obtained by the process, or by various manufacturing methods. For details, reference can be made to the formulation examples in Examples below.
- Comparative example 1 100 mL of an aqueous solution containing 10% taurine and 0.1% cyanocobalamin was heated to 50°C to uniformly dissolve it, then allowed to cool to room temperature, and after standing for 24 hours, the precipitated crystals were filtered off and dried to obtain a pink crystalline substance. Ta.
- Comparative example 2 100 mL of an aqueous solution containing 10% taurine, 0.1% cyanocobalamin, and 15 mL of ethanol was heated to 50°C to dissolve it uniformly, then allowed to cool to room temperature, and after standing for 24 hours, the precipitated crystals were filtered and dried to form pink crystals. I got something.
- Comparative example 3 100 mL of an aqueous solution containing 10% taurine, 5.0% nicotinic acid amide, and 15 mL of ethanol was heated to 50°C to uniformly dissolve it, then allowed to cool to room temperature, and after standing for 24 hours, the precipitated crystals were filtered and dried. Colorless and transparent crystals were obtained. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain nicotinic acid amide.
- Comparative example 4 100 mL of an aqueous solution containing 10% taurine, 5.0% nicotinic acid amide, and 15 mL of ethanol was heated to 50 °C to dissolve uniformly, then cooled to 30 °C while stirring with a spatula, and the precipitated crystals were filtered and dried. Colorless and transparent crystals were obtained. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain nicotinic acid amide.
- Comparative example 5 After heating 100 mL of an aqueous solution containing 10% taurine, 10% glycerin, and 0.0008% nicotinic acid amide to 50 °C to uniformly dissolve it, cool it to 30 °C with stirring, and slowly pour 15 mL of ethanol to separate into two phases. The crystals precipitated at the interface were separated by filtration, washed with ethanol, and then dried. When the obtained crystals were analyzed by high performance liquid chromatography, nicotinamide was not detected.
- Comparative example 6 After heating 100 mL of an aqueous solution containing 2.5% taurine to 50°C and dissolving it uniformly, it was cooled to 30°C while stirring, and after standing, 80 mL of an ethanol solution containing 5% nicotinic acid amide was slowly poured into it, but the crystals remained I could't get it.
- Example 1 100 mL of an aqueous solution containing 10% taurine and 0.1% cyanocobalamin was heated to 60°C and dissolved uniformly, then cooled to 30°C with stirring, and 15 mL of 1,3-butanediol was added while stirring strongly with a disper. The precipitated crystals were separated by filtration, washed with ethanol, and dried to obtain pink crystals.
- Example 2 After heating 100 mL of an aqueous solution containing 10% taurine and 10% glycerin to 50 °C to uniformly dissolve it, cool it to 30 °C with stirring, and add 15 mL of an ethanol solution containing 1.0% cyanocobalamin with strong stirring with a disper. The precipitated crystals were separated by filtration, washed with ethanol, and dried to obtain pink crystals.
- Example 3 After heating 100 mL of an aqueous solution containing 15% taurine to 50°C and dissolving it uniformly, it was cooled to 40°C while stirring, left to stand, and then slowly poured 15 mL of an ethanol solution containing 1% cyanocobalamin heated to 40°C. Crystals precipitated at the interface between the phases were separated by filtration, washed with ethanol, and dried to obtain pink crystals.
- Example 4 100 mL of an aqueous solution containing 10% taurine was heated to 50°C to dissolve uniformly, then cooled to 30°C with stirring, left to stand, and then slowly poured into 15 mL of an ethanol solution containing 5% nicotinic acid amide to separate into two phases. Crystals precipitated at the interface were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain nicotinic acid amide.
- Example 5 After heating 100 mL of an aqueous solution containing 5% taurine to 50°C and dissolving it uniformly, it was cooled to 30°C with stirring, left to stand, and then slowly poured with 15 mL of an ethanol solution containing 5% 3-O-ethyl ascorbic acid. Crystals precipitated at the interface between the phases were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain 3-O-ethyl ascorbic acid.
- Example 6 100 mL of an aqueous solution containing 20% taurine and 3% dipotassium glycyrrhizinate was heated to 70°C to dissolve uniformly, then cooled to 50°C with stirring, left to stand, and then heated to 50°C, followed by 15 mL of 1,3-propanediol. was poured slowly, and the crystals precipitated at the interface where the two phases separated were separated by filtration, washed with a 50% aqueous ethanol solution, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain dipotassium glycyrrhizinate.
- Example 7 After heating 100 mL of an aqueous solution containing 8% taurine to 50 °C and uniformly dissolving it, cool it to 30 °C while stirring, and after standing still, slowly pour 15 mL of an ethanol solution containing 5% L-ascorbic acid-2-glucoside, Crystals precipitated at the interface between the two phases were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain L-ascorbic acid-2-glucoside.
- Example 8 100 mL of an aqueous solution containing 25% taurine and 5% arbutin was heated to 80°C to dissolve it uniformly, then allowed to stand, and 15 mL of 1,3-butylene glycol heated to 80°C was slowly poured into the interface, which separated into two phases. The precipitated crystals were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain arbutin.
- Example 9 After heating 100 mL of an aqueous solution containing 10% taurine to 50 °C and uniformly dissolving it, cool it to 30 °C while stirring, and leave it to stand. After slowly pouring 15 mL of an ethanol solution containing 10% ascorbyl tetrahexyl decanoate, the mixture was separated into two phases. Crystals precipitated at the interface were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain ascorbyl tetrahexyldecanoate.
- Example 10 100 mL of an aqueous solution containing 15% taurine and 0.01% allantoin was heated to 60°C to uniformly dissolve it, then cooled to 40°C with stirring, left to stand, and then slowly poured 15 mL of ethanol to form an interface separated into two phases. The precipitated crystals were separated by filtration, washed with a 50% ethanol aqueous solution, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain allantoin.
- Example 11 After heating 100 mL of an aqueous solution containing 12% taurine to 50 °C and uniformly dissolving it, cool it to 30 °C while stirring, and leave it to stand. After slowly pouring 15 mL of an ethanol solution containing 0.1% tocopherol acetate, the mixture was separated into two phases. Crystals precipitated at the interface were separated by filtration, washed with ethanol, and dried to obtain colorless and transparent crystals. The obtained crystals were analyzed by high performance liquid chromatography and confirmed to contain tocopherol acetate.
- Example 12 100 mL of an aqueous solution containing 10% taurine and 0.5% sodium copper chlorophyllin was heated to 50°C to dissolve uniformly, then cooled to 30°C while stirring, left to stand, and then slowly poured 15 mL of ethanol to separate into two phases. The crystals precipitated at the interface were separated by filtration, washed with a 50% aqueous ethanol solution, and dried to obtain a green crystalline substance.
- Example 13 100 mL of an aqueous solution containing 10% taurine and 1% gardenia blue was heated to 50°C to uniformly dissolve it, cooled to 30°C while stirring, left to stand, and then slowly poured 15 mL of ethanol to dissolve the mixture at the interface where the two phases separated. The precipitated crystals were separated by filtration, washed with 50% ethanol aqueous solution, and dried to obtain blue crystals.
- Example 14 After heating 100 mL of an aqueous solution containing 12% taurine to 50°C and dissolving it uniformly, it was cooled to 35°C with stirring, left to stand, and then slowly poured 15 mL of an ethanol solution containing 5% ubidecarenone heated to 40°C. Crystals precipitated at the interface between the phases were separated by filtration, washed with ethanol heated to 40°C, and dried to obtain pale yellow needle-like crystals containing ubidecarenone.
- Example 15 After heating 100 mL of an aqueous solution containing 10% taurine to 50°C and uniformly dissolving it, cool it to 35°C while stirring, and leave it to stand. Company) Slowly pour 15 mL of a 3% ethanol solution, filter out the crystals precipitated at the interface where the two phases separated, wash with ethanol heated to 40°C, dry, and form pale pink needles containing ⁇ -carotene. Obtained crystals.
- Example 16 After heating 100 mL of an aqueous solution containing 8% taurine to 50 °C and uniformly dissolving it, cooling it to 35 °C while stirring, and leaving it to stand, an ethanol solution containing 3% astaxanthin solution (astaxanthin-5C: Oryza Yuka Co., Ltd.) 15 mL was slowly poured, and the crystals precipitated at the interface where the two phases separated were filtered out, washed with ethanol heated to 40°C, and dried to obtain orange needle-shaped crystals containing astaxanthin.
- an ethanol solution containing 3% astaxanthin solution (astaxanthin-5C: Oryza Yuka Co., Ltd.) 15 mL was slowly poured, and the crystals precipitated at the interface where the two phases separated were filtered out, washed with ethanol heated to 40°C, and dried to obtain orange needle-shaped crystals containing astaxanthin.
- the taurine concentration in phase A was set to be a saturated concentration at 25 °C, and phase B was added to phase A heated to 80 °C while mixing with a homomixer, and after cooling to 25 °C.
- a crystal-containing emulsion was prepared by mixing the taurine crystals of the D layer with the obtained composition.
- phase A was heated to 100°C, mixed, cooled to 25°C, and taurine crystals of layer B were mixed to prepare a cosmetic oil containing crystals.
- the crystals obtained by the production method of the present invention form fine needle-like or columnar crystals, and by controlling the crystal size, the blended product has a rough feel when used. No feeling was observed, and it was confirmed that the usability was clearly improved.
- Example 17 100 mL of an aqueous solution containing 10% by mass of taurine and 10% by mass of glycerin was heated to 50°C to uniformly dissolve it, cooled to 40°C with stirring, left to stand, and then heated to 40°C.
- a microscopic photograph of the obtained crystalline product is shown in Figure 4-7. As shown in Figure 4-7, the shape of the obtained taurine microcrystals was needle-like.
- the fine needle-like crystals had a maximum thickness of 30 micrometers and a maximum length of 230 micrometers. As shown in FIGS. 5 and 7, when the obtained crystals were observed under a fluorescence microscope, it was confirmed that uranine was encapsulated within the crystals.
- Example 18 The following composition containing the crystals obtained in Example 17 was prepared, and the penetration of the encapsulated ingredients into the skin was evaluated.
- the A phase which was heated to 80°C and uniformly dissolved, was cooled to 35°C, and while stirring, the B phase was added, and the mixture was stirred at 35°C for 10 minutes.
- Phase C was added to this and stirred for 10 minutes to mix uniformly to obtain an aqueous gel composition.
- the obtained composition was applied to excised human skin (thickness 700 micrometers) (provided by a US tissue bank), and fluorescence observation of a cross section of the skin after 5 minutes revealed that fine needle-like crystals containing uranine were stuck. It was confirmed that it reached the stratum corneum, epidermis, and dermis ( Figure 8). Furthermore, when the condition was observed after 30 minutes, it was confirmed that the crystals stuck in the skin had dissolved and uranine had diffused into the skin ( Figure 9).
- Example 19 and Comparative Example 7 Fine needle-like crystals containing dipotassium glycyrrhizinate were prepared, and the amount of dipotassium glycyrrhizinate permeated into the skin was measured. 100 mL of an aqueous solution containing 10% by mass of taurine and 3% by mass of dipotassium glycyrrhizinate was heated to 60°C to dissolve uniformly, then cooled to 40°C with stirring, left to stand, and then slowly poured 15mL of ethanol to separate into two phases. The crystals precipitated at the interface were separated by filtration, washed with ethanol, and dried to obtain a crystal. The shape of the obtained taurine microcrystals was needle-like.
- the fine needle-like crystals had a maximum thickness of 30 micrometers and a maximum length of 180 micrometers. Further, when the obtained crystals were analyzed by liquid chromatography, it was confirmed that 0.101% by mass of dipotassium glycyrrhizinate was contained.
- the compositions shown in the table below containing 10% by mass of these fine needle-like crystals and the compositions of comparative examples in which dipotassium glycyrrhizinate was dissolved to the same concentration were prepared, and the resulting compositions were applied to human skin. The amount of dipotassium glycyrrhizinate that permeated into the skin when applied was compared.
- the amount of penetration into the skin was evaluated using a vertical Franz-type diffusion cell with an effective diameter of 2.0 cm, an area of 3.14 cm2, and a receptor liquid volume of 2.4 mL, and each sample was extracted from a human at 10.0 mg/cm2. applied to the skin. After 6 hours, the stratum corneum and epidermis/dermis were separated from the sample skin by tape stripping, and dipotassium glycyrrhizinate contained in the stratum corneum, epidermis/dermis, and receptor solution was quantified using high performance liquid chromatography.
- Example 19 penetrated about 2.5 times as much dipotassium glycyrrhizinate throughout the skin as compared to the composition of Comparative Example 7, and It was confirmed that by incorporating the useful ingredient into the skin, the useful ingredient penetrated into the epidermis, dermis, and receptor fluid.
- Phase A which was heated to 80°C and uniformly dissolved, was cooled to 35°C, added to phase B while stirring, and stirred at 35°C for 10 minutes.
- Phase C was added thereto and stirred for 10 minutes using a homomixer to mix uniformly, then crystals of phase D were added and stirred for 5 minutes to obtain a lotion composition.
- the shape of the taurine microcrystals in the obtained composition was needle-like, with a maximum thickness of 30 micrometers and a maximum length of 300 micrometers, and the composition had a smooth feel when used, resulting in a composition with a good feeling of use. was gotten.
- Phase A which was heated to 80°C and uniformly dissolved, was cooled to 35°C, added to phase B while stirring, and stirred at 35°C for 10 minutes to precipitate fine needle-like crystals of taurine.
- Phase C was added thereto and stirred for 10 minutes using a homomixer to mix uniformly, then crystals of phase D were added and stirred for 5 minutes to obtain an aqueous gel composition.
- the shape of the fine crystals of taurine in the obtained composition was needle-like, with a maximum thickness of 30 micrometers and a maximum length of 230 micrometers.
- the resulting composition had a smooth feeling on use, and a composition with a good feeling on use was obtained.
- [Emulsion] [A] Purified water 60.20% by mass Taurine 8.00% by mass Glycerin 5.00% by mass [B] 1,3-propanediol 15.00% by mass 3-O-ethyl ascorbic acid 3.00% by mass Pentylene glycol 1.50% by mass Phenoxyethanol 0.30% by mass [C] (Hydroxyethyl acrylate/Na acryloyldimethyltaurine) copolymer 0.75% by mass Isohexadecane 0.45% by mass Polysorbate 80 0.15% by mass Purified water 0.65% by mass [D] Squalane 5.00% by mass
- Phase A which was heated to 80°C and uniformly dissolved, was cooled to 35°C, added to phase B while stirring, and stirred at 35°C for 10 minutes to precipitate fine needle-like crystals of taurine.
- the mixture of phase C was added thereto and stirred for 5 minutes with a homomixer to mix uniformly, then phase D was added and stirred for 10 minutes with a homomixer to emulsify to obtain a milky lotion composition.
- the shape of the fine crystals of taurine in the obtained composition was needle-like, with a maximum thickness of 30 micrometers and a maximum length of 250 micrometers, and high performance liquid chromatography analysis revealed that 3-O-ethyl ascorbic acid It was confirmed that it was contained.
- the resulting composition had a smooth feeling on use, and a composition with a good feeling on use was obtained.
- [O/W type cream] [A] Purified water 63.00% by mass Taurine 8.00% by mass Glycerin 5.00% by mass Nicotinic acid amide 5.00% by mass [B] 1,3-propanediol 15.00% by mass Pentylene glycol 1.50% by mass Phenoxyethanol 0.30% by mass [C] (Hydroxyethyl acrylate/Na acryloyldimethyltaurine) copolymer 0.75% by mass Polysorbate 80 0.15% by mass Purified water 0.65% by mass [D] Squalane 0.65% by mass
- Phase A which was heated to 80°C and uniformly dissolved, was cooled to 35°C, added to phase B while stirring, and stirred at 35°C for 10 minutes to precipitate fine needle-like crystals of taurine.
- the mixture of phase C was added thereto and stirred for 5 minutes using a homomixer to mix uniformly, then phase D was added and stirred for 10 minutes using a homomixer to emulsify to obtain an O/W type cream composition.
- the shape of the fine crystals of taurine in the obtained composition was needle-like, with a maximum thickness of 30 micrometers and a maximum length of 250 micrometers, and analysis by high performance liquid chromatography revealed that nicotinic acid amide was contained. This was confirmed.
- the resulting composition had a smooth feeling on use, and a composition with a good feeling on use was obtained.
- [W/O type cream] [A] Purified water 32.30% by mass Taurine 7.00% by mass Glycerin 5.00% by mass L-ascorbic acid-2-glucoside 2.00% by mass [B] 1,3-propanediol 9.00% by mass 1,2-hexanediol 0.70% by mass Phenoxyethanol 0.30% by mass [C] Isopropyl myristate 33.70% by mass Jojoba oil 5.00% by mass Polyglyceryl-6 polyricinoleate 3.25% by mass Polyglyceryl-2 isostearate 1.00% by mass Disteardimonium hectorite 0.75% by mass
- Phase A which was heated to 80°C and uniformly dissolved, was cooled to 35°C, added to phase B while stirring, and stirred at 35°C for 10 minutes to precipitate fine needle-like crystals of taurine.
- This liquid mixture was added to the homogeneously mixed phase C over 5 minutes using a homomixer, and then stirred using a homomixer for 10 minutes to emulsify, thereby obtaining a W/O type cream composition.
- the shape of the fine crystals of taurine in the obtained composition was needle-like, with a maximum thickness of 25 micrometers and a maximum length of 200 micrometers, and high-performance liquid chromatography analysis revealed that L-ascorbic acid-2-glucoside It was confirmed that it contained
- the resulting composition had a smooth feeling on use, and a composition with a good feeling on use was obtained.
- Phase A was heated to 100°C and stirred until homogeneous. This was cooled to 35°C, phase B was added, and stirred to uniformly disperse the mixture to obtain a cosmetic oil composition.
- the shape of the fine crystals of taurine in the obtained composition was needle-like, with a maximum thickness of 40 micrometers and a maximum length of 520 micrometers.
- the resulting composition had a smooth feeling on use, and a composition with a good feeling on use was obtained.
- Test example 1 In the taurine containing various useful ingredients produced above, a test was conducted to demonstrate that the useful ingredients were included in the taurine crystals. Described below are the results of X-ray diffraction of the astaxanthin-containing taurine needle crystals produced in Example 14. As a control, needle-shaped crystals of taurine alone were produced by the following steps. After heating 100 mL of an aqueous solution containing 10% taurine to 50 °C and uniformly dissolving it, cool it to 30 °C with stirring, leave it to stand, and then slowly pour in 15 mL of ethanol, and filter the crystals precipitated at the interface where the two phases separated. Separately, the crystals were washed with ethanol and dried to obtain colorless and transparent crystals.
- X-ray diffraction of taurine needle crystals and astaxanthin-containing taurine needle crystals was performed using an X-ray diffraction apparatus manufactured by Rigaku Co., Ltd., model number SmartLab.
- the obtained X-ray diffraction pattern is shown in FIG.
- the top is a diffraction pattern from an astaxanthin-containing taurine crystal
- the bottom is a diffraction pattern from a taurine crystal.
- the diffraction angles of the 111 plane and the 200 plane are summarized in Table 8 below. Specifically, the lattice constant was calculated from the following data for the spread of the 111 plane and the 200 plane using Bragg's formula (a decrease in 2 ⁇ indicates a spread of the interplanar spacing).
- FIG. 2 An example of an optical micrograph of a crystal obtained by the present invention is shown in FIG. 2. This crystal was obtained in Example 3. An example of a microscopic photograph of crystals of raw material taurine is shown in FIG. As the raw material taurine, Japanese Pharmacopoeia taurine (manufactured by Koka Pharmaceutical Co., Ltd.) was used.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Geometry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
また、結晶に他の成分を含有させる技術については、該技術に用いられる組成物は、水が存在しない状態での粉末の混合物であったり、油類の中に分散状態で存在させた組成物であったりするものであり、非水系での利用に用途が限定されるものであった。
水溶性結晶内に、有用な有機化合物、ペプチド、色素などを安定的に含有することができれば、結晶に着色をすることや、様々な製剤中に安定的に有用成分を配合することが可能となる。本発明の目的は、有用成分の皮内への新たな送達手段を提供することにある。
〔1〕 結晶中に有用成分を包含するタウリンの微細針状結晶を含有することを特徴とする皮膚外用剤組成物。
〔2〕 前記タウリンの微細針状結晶が少なくとも一部分散されて含有していることを特徴とする、〔1〕に記載の皮膚外用剤組成物。
〔3〕 前記タウリンの微細針状結晶中に空間を有し、該空間中に有用成分が内包されていることを特徴とする、〔1〕又は〔2〕に記載の皮膚外用剤組成物。
〔4〕 前記タウリンの微細針状結晶中の空間容積が、タウリン結晶体積中の0.001%~30%を占めることを特徴とする、〔3〕に記載の皮膚外用剤組成物。
〔5〕 前記タウリンの微細針状結晶の太さが150マイクロメートル以下、長さが3000マイクロメートル以下である、〔1〕~〔4〕のいずれかに記載の皮膚外用剤組成物。
〔6〕 前記有用成分が、ビタミン類及びビタミン誘導体、ハイドロキノン及びその誘導体、美白成分、抗炎症成分、抗酸化成分、血行促進成分、細胞賦活成分、補酵素及びその中間代謝物、糖類、植物抽出成分、ペプチド、タンパク質、並びに色素からなる群より選ばれる1種又は2種以上であることを特徴とする、〔1〕~〔5〕のいずれかに記載の皮膚外用剤組成物。
〔7〕 前記タウリンの微細針状結晶中の前記有用成分の包含率が0.001%~30%であることを特徴とする、〔1〕~〔6〕のいずれかに記載の皮膚外用剤組成物。
〔8〕 さらに、皮膚外用剤組成物媒体中にも有用成分が溶解ないし分散している、〔1〕~〔7〕のいずれかに記載の皮膚外用剤組成物。
〔9〕 タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程を含み、ここで、該水溶液(A)中又は該液体物質(B)中に有用成分が溶解又は分散していることにより、該有用成分は、結晶成長に伴って該結晶に包含されることを特徴とする、結晶中に有用成分を包含するタウリンの微細針状結晶の製造方法。
〔10〕 前記液体物質(B)が水溶性有機溶媒であることを特徴とする、〔9〕に記載の製造方法。
〔11〕 前記水溶性有機溶媒が、エタノール、イソプロピルアルコール、エチレングリコール、1,2-プロパンジオール、1,3-プロパンジオール、1,2-ブタンジオール、1,3-ブタンジオール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,2-ペンタンジオール、1,2-ヘキサンジオール、シクロヘキシルグリセリン、及びn-ヘキシルグリセリンからなる群より選ばれる1種又は2種以上であることを特徴とする、〔10〕に記載の製造方法。
〔12〕 前記有用成分の濃度が、前記水溶液(A)中又は前記液体物質(B)中、0.001質量%以上であることを特徴とする、〔9〕~〔11〕のいずれかに記載の製造方法。
〔13〕 前記水溶液(A)中のタウリンの濃度が3~28質量%であることを特徴とする、〔9〕~〔12〕のいずれかに記載の製造方法。
〔14〕 前記液体物質(B)が、前記水溶液(A)の全量に対して50質量%以下であることを特徴とする、〔9〕~〔13〕のいずれかに記載の製造方法。
〔15〕 結晶中に有用成分を包含するタウリンの微細針状結晶を含有する皮膚外用剤組成物の製造方法であって、下記工程:
タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程、ここで、該水溶液(A)中又は該液体物質(B)中に有用成分が溶解又は分散していることにより、該有用成分は、結晶成長に伴って該結晶に包含される、及び、
前記結晶成長させる工程で得られた、結晶中に有用成分を包含するタウリンの微細針状結晶を皮膚外用剤組成物に配合する工程、
を含む、製造方法。
〔16〕 前記有用成分の濃度が、前記水溶液(A)中又は前記液体物質(B)中、0.001質量%以上であることを特徴とする、〔15〕に記載の製造方法。
〔17〕 前記水溶液(A)中のタウリンの濃度が3~28質量%であることを特徴とする、〔15〕又は〔16〕に記載の製造方法。
〔18〕 前記液体物質(B)が、前記水溶液(A)の全量に対して50質量%以下であることを特徴とする、〔15〕~〔17〕のいずれかに記載の製造方法。
〔19〕 前記液体物質(B)が水溶性有機溶媒であり、前記水溶性有機溶媒が、エタノール、イソプロピルアルコール、エチレングリコール、1,2-プロパンジオール、1,3-プロパンジオール、1,2-ブタンジオール、1,3-ブタンジオール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,2-ペンタンジオール、1,2-ヘキサンジオール、シクロヘキシルグリセリン、及びn-ヘキシルグリセリンからなる群より選ばれる1種又は2種以上であることを特徴とする、〔15〕~〔18〕のいずれかに記載の製造方法。
上記タウリンの微細針状結晶は、タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)(例えば、水溶性有機溶媒)と混合すること、または、タウリンが溶解した水溶液(A)とタウリンの溶解性の低い液体物質(B)(例えば、水溶性有機溶媒)とを接触させること(例えば、水溶液(A)に液体物質(B)を静かに注ぐことで界面を形成させること)、等により、タウリンの極端に溶解度の低い状態を作り出し、そこで再結晶を進行させること(結晶成長させること)で製造することが可能である。得られるタウリンの微細針状結晶は、結晶形が制御されている。また、結晶を製造する際にタウリンの微細針状結晶中に中空部分が形成されるが、この中空部分を空間容積と定義する。
したがって、上記タウリンの微細針状結晶は、該タウリンの微細針状結晶中に空間を有する。上記タウリンの微細針状結晶の上記空間容積は、タウリン結晶体積中の0.001%~30%を占めることが好ましく、0.1%~30%を占めることがより好ましい。ここで、タウリン微細針状結晶の空間容積の大きさは、結晶の顕微鏡写真を解析することにより算定される。
本発明におけるタウリンの微細結晶は、針状結晶であるが、柱状結晶であってもよい。ここで、針状結晶とは、結晶の長径が短径の3倍以上の形状をいい、柱状結晶とは、結晶の長径が短径の3倍未満の形状をいう。本発明におけるタウリンの微細針状又は柱状結晶は、原料タウリンの塊状結晶とは顕微鏡観察により区別できる結晶形である。微細針状結晶の一例を図2に示し、塊状結晶の一例を図3に示す。以下、本発明に使用するタウリン再結晶を、タウリン微細針状結晶と称する。
タウリン微細針状結晶の大きさは、皮膚外用剤組成物に含有させて使用する時にザラザラとした感触が残らず、さらさらとした塗布感を付与する観点から、太さが150マイクロメートル以下、長さが3000マイクロメートル以下であることが好ましく、太さが5~150マイクロメートル、長さが100~3000マイクロメートルであることがより好ましく、太さが10~100マイクロメートル、長さが100~2000マイクロメートルであることが更に好ましく、太さが10~60マイクロメートル、長さが150~2000マイクロメートルであることが最も好ましい。
ここで、太さとは結晶の短径であり、長さとは結晶の長径である。結晶の太さ及び長さは、デジタルマイクロスコープ(例えば、株式会社キーエンス製「デジタルマイクロスコープ VHX-7000」)を用いて計測することができる。
太さが150マイクロメートルを超えかつ長さが3000マイクロメートルを超える結晶形(例えば、原料として市販されている、タウリン結晶及びタウリン結晶性粉末)は、塗布時にザラザラとした異物感が肌上に残るため好ましくない。
具体的な再結晶(結晶成長)条件とは、タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程である。
前記ビタミン類およびビタミン誘導体、ハイドロキノンおよびその誘導体、美白成分、抗炎症成分、抗酸化成分、血行促進成分、細胞賦活成分、補酵素およびその中間代謝物には、例えば、ニコチン酸アミド、グリチルリチン酸塩、トラネキサム酸、L-アスコルビン酸-2-グルコシド、アスコルビルリン酸ナトリウム、グリセリルアスコルビン酸、ビスグリセリルアスコルビン酸、3-グリセリルアスコルビン酸、ヘキシル3-グリセリルアスコルビン酸、ミリスチル3-グリセリルアスコルビン酸、3-ラウリルグリセリルアスコルビン酸、アルブチン、コウジ酸、アラントイン、シアノコバラミン、リボフラビン、ピリドキシン塩、グルコシルヘスペリジン、テトラヘキシルデカン酸アスコルビル、3-O-エチルアスコルビン酸、酢酸トコフェロール、銅クロロフィリンナトリウム、葉酸、ハイドロキノン、ユビキノン、ピロロキノリンキノン、トパキノン、トリプトファン-トリプトフィルキノン、リシンチロシルキノン、システニル-トリプトファンキノン、チアミン二リン酸、パントテン酸、ビオチン、アデノシン三リン酸、ウリジン二リン酸グルコース、リボヌクレオチド、デオキシヌクレオチド、ニコチンアミドモノヌクレオチド、β-カロテン、アスタキサンチンが含まれる。
前記糖類には、D-グリセリルアルデヒド、ジヒドロキシアセトン、D-エリトロ-ス、D-エリトルロ-ス、Dートレオ-ス、エリスリトール、L-アラビノ-ス、D-キシロ-ス、L-リキソ-ス、D-アラビノ-ス、D-リボ-ス、D-リブロ-ス、D-キシルロ-ス、L-キシルロ-ス、D-グルコ-ス、D-タロ-ス、D-ブシコ-ス、D-ガラクト-ス、D-フルクト-ス、L-ガラクト-ス、L-マンノ-ス、D-タガト-ス、アルドヘプト-ス、ヘプロ-ス、オクツロ-ス等、2-デオキシ-D-リボ-ス、6-デオキシ-L-ガラクト-ス、6-デオキシ-L-マンノ-ス、D-グルコサミン、D-ガラクトサミン、シアル酸、アミノウロン酸、ムラミン酸等、D-グルクロン酸、D-マンヌロン酸、L-グルロン酸、D-ガラクツロン酸、L-イズロン酸ソルビトール、スクロース、マンニトール、フルクトース、ラフィノース、マルトース、キシリトール、マルチトール、パラチノース、アラビノース、マルトトリオ-ス、ショ糖、エリトリトール、グルコ-ス、デンプン分解糖、グンチアノース、ウンベリフェロース、ラクトース、プランテオース、イソリクノース類、トレハロース、リクノース類、ウンビリシン、スタキオースベルバスコース、加水分解水添デンプン、グリセルグルコシドが含まれる。
前記植物抽出成分には、例えば、オタネニンジン、アシタバ、アルニカ、イチョウ、ウイキョウ、ウコン、エンメイソウ、オランダカシ、カミツレ、ローマカミツレ、カロット、ゲンチアナ、ゴボウ、コメ、サンザシ、シイタケ、ショウガ、セイヨウサンザシ、セイヨウネズ、センキュウ、センブリ、タイム、チョウジ、チンピ、トウガラシ、トウキ、トウニン、トウヒ、ニンジン、ニンニク、ブッチャーブルーム、ブドウ、ボタン、マロニエ、メリッサ、ユズ、ヨクイニン、リョクチャ、ローズマリー、ローズヒップ、チンピ、トウキ、トウヒ、モモ、アンズ、クルミ、トウモロコシ、ゴールデンカモミール、イクタモール、カンタリスチンキ、セファランチンが含まれる。
前記ペプチドには、(アルギニン/リシン)ポリペプチド、3-アスコルビルカルボニルジペプチド、アセチルシクロヘキサペプチド、アセチルテトラペプチド、アセチルテトラペプチド、アセチルテトラペプチド、アセチルテトラペプチド、アセチルヘキサペプチド、アセチルヘキサペプチド、アセチルヘプタペプチド、アセチルペンタペプチド、オリゴペプチド、カフェオイルトリペプチド、カプリロイルジペプチド、カプリロイル合成ヒトノナペプチド、ジペプチド、ジ酢酸ジペプチドジアミノブチロイルベンジルアミド、デカペプチド、テトラペプチド、トリフルオロアセチルトリペプチド、トリペプチド、トリペプチド-1銅、ノナペプチド、パルミチン酸ヘプタペプチド、パルミトイルオクタペプチド、パルミトイルオリゴペプチド、パルミトイルジペプチド、パルミトイルジペプチド-5ジアミノヒドロキシ酪酸、パルミトイルジペプチド-5ジアミノブチロイルヒドロキシトレオニン、パルミトイルテトラペプチド、ヒト遺伝子組換オリゴペプチド、ヒト遺伝子組換ポリペプチド、合成ヒトノナペプチド、酢酸N-プロリルパルミトイルトリペプチド、酢酸ヘキサノイルジペプチド-3ノルロイシンが含まれる。
前記タンパク質には、アーモンドタンパク、コメタンパク、コムギタンパク、コムギ胚芽タンパク、ダイズタンパク、トウモロコシグルテンタンパク、真珠層タンパクが含まれる。
前記色素には、天然色素と合成色素が含まれ、天然色素としては、例えば、クチナシ黄色素、ベニバナ黄色素、ウコン色素、ベニコウジ黄色素、マリーゴールド色素、ベニコウジ色素、クチナシ赤色素、ベニバナ赤色素、トマト色素、コチニール色素、シソ色素、アカキャベツ色素、アカダイコン色素、ムラサキイモ色素、ブドウ果皮色素、カカオ色素、カラメル色素、クチナシ青色素、など、合成色素としては、例えば、赤色201号、赤色202号、赤色204号、赤色205号、赤色220号、赤色226号、赤色228号、赤色405号、橙色203号、橙色204号、黄色205号、黄色401号、及び青色404号等の有機顔料、赤色3号、赤色104号、赤色106号、赤色227号、赤色230号、赤色401号、赤色505号、橙色205号、黄色4号、黄色5号、黄色202号、黄色203号、緑色3号及び青色1号などが挙げられる。
タウリンの微細針状結晶に、上記有用成分を、1種または2種以上を包含させることが可能である。
包含する有用成分の量は、結晶全体の重量に占める有用成分の包含量を包含率として示すことができる。上記タウリンの微細針状結晶中の上記有用成分の包含率は、0.001~30質量%であることが好ましく、0.001~25質量%であることがより好ましく、0.001~20質量%であることが最も好ましい。0.001%質量未満では包含する有用成分の効果が十分に得られないため、好ましくない。
化粧油剤、軟膏剤については、有用成分包含タウリン微細針状結晶は、ろ過、乾燥したものを配合することで調製することが可能である。
タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程、ここで、該水溶液(A)中又は該液体物質(B)中に有用成分が溶解又は分散していることにより、該有用成分は、結晶成長に伴って該結晶に包含される、及び、
前記結晶成長させる工程で得られた、結晶中に有用成分を包含するタウリンの微細針状結晶を皮膚外用剤組成物に配合する工程。
タウリン10%、シアノコバラミン0.1%を含む水溶液100mLを50℃に加温し均一溶解後、室温まで放冷し、24時間静置後析出した結晶を濾別、乾燥し、桃色結晶物を得た。
タウリン10%、シアノコバラミン0.1%、エタノール15mLを含む水溶液100mLを50℃に加温し均一溶解後、室温まで放冷し、24時間静置後析出した結晶を濾別、乾燥し、桃色結晶物を得た。
タウリン10%、ニコチン酸アミド5.0%、エタノール15mLを含む水溶液100mLを50℃に加温し均一溶解後、室温まで放冷し、24時間静置後析出した結晶を濾別、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、ニコチン酸アミドが含有されていることを確認した。
タウリン10%、ニコチン酸アミド5.0%、エタノール15mLを含む水溶液100mLを50℃に加温し均一溶解後、スパチュラで攪拌しながら30℃まで冷却し、析出した結晶を濾別、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、ニコチン酸アミドが含有されていることを確認した。
タウリン10%、グリセリン10%、ニコチン酸アミド0.0008%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥させた。得られた結晶を高速液体クロマトグラフィーで分析したところ、ニコチン酸アミドは検出されなかった。
タウリン2.5%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、ニコチン酸アミド5%含有エタノール溶液80mLをゆっくりと注いだが、結晶は得られなかった。
タウリン10%、シアノコバラミン0.1%を含む水溶液100mLを60℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、15mLの1,3-ブタンジオールをディスパーで強攪拌しながら添加し、析出した結晶を濾別、エタノールで洗浄後、乾燥し、桃色結晶物を得た。
タウリン10%、グリセリン10%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、シアノコバラミン1.0%含有エタノール溶液15mLをディスパーで強攪拌しながら添加し、析出した結晶を濾別、エタノールで洗浄後、乾燥し、桃色結晶物を得た。
タウリン15%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら40℃まで冷却し、静置後、40℃に加温したシアノコバラミン1%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、桃色結晶物を得た。
タウリン10%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、ニコチン酸アミド5%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、ニコチン酸アミドが含有されていることを確認した。
タウリン5%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、3-O-エチルアスコルビン酸5%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、3-O-エチルアスコルビン酸が含有されていることを確認した。
タウリン20%、グリチルリチン酸ジカリウム3%を含む水溶液100mLを70℃に加温し均一溶解後、攪拌しながら50℃まで冷却し、静置後、50℃に加温した1,3-プロパンジオール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、50%エタノール水溶液で洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、グリチルリチン酸ジカリウムが含有されていることを確認した。
タウリン8%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、L-アスコルビン酸-2-グルコシド5%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、L-アスコルビン酸-2-グルコシドが含有されていることを確認した。
タウリン25%およびアルブチン5%を含む水溶液100mLを80℃に加温し均一溶解後、静置し、80℃に加温した1,3-ブチレングリコール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、アルブチンが含有されていることを確認した。
タウリン10%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、テトラヘキシルデカン酸アスコルビル10%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、テトラヘキシルデカン酸アスコルビルが含有されていることを確認した。
タウリン15%、アラントイン0.01%を含む水溶液100mLを60℃に加温し均一溶解後、攪拌しながら40℃まで冷却し、静置後、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、50%エタノール水溶液で洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、アラントインが含有されていることを確認した。
タウリン12%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、酢酸トコフェロール0.1%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。得られた結晶を高速液体クロマトグラフィーで分析し、酢酸トコフェロールが含有されていることを確認した。
タウリン10%、銅クロロフィリンナトリウム0.5%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、50%エタノール水溶液で洗浄後、乾燥し、緑色結晶物を得た。
タウリン10%、クチナシ青1%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、50%エタノール水溶液で洗浄後、乾燥し、青色結晶物を得た。
タウリン12%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら35℃まで冷却し、静置後、40℃に加温したユビデカレノン5%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、40℃に加温したエタノールで洗浄後、乾燥し、ユビデカレノンを含む淡黄色の針状結晶を得た。
タウリン10%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら35℃まで冷却し、静置後、β-カロテンの懸濁液(β-カロテン30%懸濁液:DSM株式会社)3%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、40℃に加温したエタノールで洗浄後、乾燥し、β-カロテンを含む淡桃色の針状結晶を得た。
タウリン8%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら35℃まで冷却し、静置後、アスタキサンチン溶解液(アスタキサンチン-5C:オリザ油化株式会社)3%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、40℃に加温したエタノールで洗浄後、乾燥し、アスタキサンチンを含む橙色の針状結晶を得た。
化粧油剤については、A相を100℃に加熱し混合後、25℃まで冷却し、B層のタウリン結晶物を混合することで結晶を含有した化粧油剤を調製した。
タウリン10質量%、グリセリン10質量%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら40℃まで冷却し、静置後、40℃に加温したウラニン(蛍光性物質)5質量%含有エタノール溶液15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、橙黄色結晶物を得た。得られた結晶物の顕微鏡写真を図4-7に示す。
図4-7に示すように、得られたタウリンの微細結晶の形状は針状であった。微細針状結晶は、最大太さ30マイクロメートル、最大長さ230マイクロメートルであった。
図5及び7に示すように、得られた結晶を蛍光顕微鏡で観察したところ、ウラニンが結晶内に内包されていることが確認された。
実施例17で得られた結晶を配合した下記の組成物を調製し、内包成分の皮内への浸透について評価を行った。
〔A〕
精製水 81.60質量%
タウリン 8.00質量%
カルボキシビニルポリマー 0.20質量%
〔B〕
アルギニン 0.20質量%
〔C〕
実施例17で得られた微細針状結晶 10.0質量%
得られた組成物をヒト摘出皮膚(厚み700マイクロメートル)(米国組織バンクから提供)に塗布し、5分後の皮膚断面の蛍光観察を行ったところ、ウラニンを含む微細針状結晶が刺さり、角層、表皮、真皮に到達していることが確認された(図8)。
さらに、30分後の状態を観察したところ、皮膚に刺さった結晶が溶解し、皮膚内にウラニンが拡散していることが確認された(図9)。
グリチルリチン酸ジカリウムを内包した微細針状結晶を調製し、グリチルリチン酸ジカリウムの皮内への浸透量について測定を行った。
タウリン10質量%、グリチルリチン酸ジカリウム3質量%を含む水溶液100mLを60℃に加温し均一溶解後、攪拌しながら40℃まで冷却し、静置後、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、結晶物を得た。
得られたタウリンの微細結晶の形状は針状であった。微細針状結晶は、最大太さ30マイクロメートル、最大長さ180マイクロメートルであった。
また、得られた結晶を液体クロマトグラフィーで分析したところ、0.101質量%のグリチルリチン酸ジカリウムが含有されていることが確認された。
この微細針状結晶10質量%を含む下表の組成物、および、これと同濃度となるようにグリチルリチン酸ジカリウムを溶解した比較例の組成物を調製し、得られた組成物をヒト皮膚に塗布した際のグリチルリチン酸ジカリウムの皮内への浸透量を比較した。
6時間後、試料皮膚よりテープストリッピングにより角質層と表皮・真皮を分離し、角質層、表皮・真皮、レセプター溶液のそれぞれに含まれているグリチルリチン酸ジカリウムを高速液体クロマトグラフにより定量を行った。
〔A〕
精製水 71.60質量%
タウリン 7.80質量%
グリセリン 5.00質量%
ジグリセリン 0.50質量%
ベタイン 0.50質量%
フェノキシエタノール 0.30質量%
〔B〕
ジプロピレングリコール 10.00質量%
1,2-ペンタンジオール 2.50質量%
〔C〕
(アクリレーツ/メタクリル酸ステアレス-20)コポリマー
0.45質量%
精製水 1.05質量%
〔D〕
実施例1で得られた結晶 0.30質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ30マイクロメートル、最大長さ300マイクロメートルであり、組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
〔A〕
精製水 71.40質量%
タウリン 8.00質量%
グリセリン 5.00質量%
ラフィノース 0.50質量%
フェノキシエタノール 0.30質量%
〔B〕
ジプロピレングリコール 10.00質量%
1,2-ペンタンジオール 2.50質量%
〔C〕
ポリアクリレートクロスポリマー-6 2.00質量%
〔D〕
実施例14で得られた結晶 0.30質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ30マイクロメートル、最大長さ230マイクロメートルであった。得られた組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
〔A〕
精製水 60.20質量%
タウリン 8.00質量%
グリセリン 5.00質量%
〔B〕
1,3-プロパンジオール 15.00質量%
3-O-エチルアスコルビン酸 3.00質量%
ペンチレングリコール 1.50質量%
フェノキシエタノール 0.30質量%
〔C〕
(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー 0.75質量%
イソヘキサデカン 0.45質量%
ポリソルベート80 0.15質量%
精製水 0.65質量%
〔D〕
スクワラン 5.00質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ30マイクロメートル、最大長さ250マイクロメートルであり、高速液体クロマトグラフィーの分析により、3-O-エチルアスコルビン酸が含有されていることが確認された。得られた組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
〔A〕
精製水 63.00質量%
タウリン 8.00質量%
グリセリン 5.00質量%
ニコチン酸アミド 5.00質量%
〔B〕
1,3-プロパンジオール 15.00質量%
ペンチレングリコール 1.50質量%
フェノキシエタノール 0.30質量%
〔C〕
(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー 0.75質量%
ポリソルベート80 0.15質量%
精製水 0.65質量%
〔D〕
スクワラン 0.65質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ30マイクロメートル、最大長さ250マイクロメートルであり、高速液体クロマトグラフィーの分析により、ニコチン酸アミドが含有されていることが確認された。得られた組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
〔A〕
精製水 32.30質量%
タウリン 7.00質量%
グリセリン 5.00質量%
L-アスコルビン酸-2-グルコシド 2.00質量%
〔B〕
1,3-プロパンジオール 9.00質量%
1,2-ヘキサンジオール 0.70質量%
フェノキシエタノール 0.30質量%
〔C〕
ミリスチン酸イソプロピル 33.70質量%
ホホバ油 5.00質量%
ポリリシノレイン酸ポリグリセリル-6 3.25質量%
イソステアリン酸ポリグリセリル-2 1.00質量%
ジステアルジモニウムヘクトライト 0.75質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ25マイクロメートル、最大長さ200マイクロメートルであり、高速液体クロマトグラフィーの分析により、L-アスコルビン酸-2-グルコシドが含有されていることが確認された。得られた組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
〔A〕
2-エチルヘキサン酸セチル 63.40質量%
水添ポリデセン 29.00質量%
水添(スチレン/イソプレン)コポリマー 7.00質量%
トコフェロール 0.10質量%
〔B〕
実施例11で得られたタウリン微細針状結晶 0.50質量%
得られた組成物中のタウリンの微細結晶の形状は針状で、最大太さ40マイクロメートル、最大長さ520マイクロメートルであった。得られた組成物の使用感は滑らかで、使用感の良好な組成物が得られた。
以上において製造した各種有用成分入りタウリンにおいて、有用成分がタウリン結晶中に包含されていることを実証する試験を実施した。以下に記載するのは実施例14において製造したアスタキサンチン入りタウリン針状結晶のX線回折の結果である。
対照として、タウリン単独の針状結晶を以下の工程により製造した。
タウリン10%を含む水溶液100mLを50℃に加温し均一溶解後、攪拌しながら30℃まで冷却し、静置後、エタノール15mLをゆっくりと注ぎ、二相に分離した界面で析出した結晶を濾別、エタノールで洗浄後、乾燥し、無色透明の結晶を得た。
株式会社リガク社製X線回折装置、型番 SmartLabを用いてタウリン針状結晶及びアスタキサンチン含有タウリン針状結晶のX線回折を実施した。X線はCuKα線(波長=0.154nm)を用い、出力45kV、200mA、検出器にHyPix-3000を使用し、2θ/θ測定法で、走査速度10°/分で、2θが10~80°の範囲について測定を行った。
得られたX線回折パターンを図1に示す。上がアスタキサンチン含有タウリン結晶、下がタウリン結晶からの回折パターンである。
上記の結果からアスタキサンチン入りタウリン結晶とタウリン結晶とは同一の回折パターンを示さない。111面と200面の回折角を下記表8にまとめる。具体的には、111面と200面の広がりをBraggの式を用いて下記のデータから格子定数を計算した(2θが小さくなることは面間隔の広がりを示す)。
Claims (19)
- 結晶中に有用成分を包含するタウリンの微細針状結晶を含有することを特徴とする皮膚外用剤組成物。
- 前記タウリンの微細針状結晶が少なくとも一部分散されて含有していることを特徴とする、請求項1に記載の皮膚外用剤組成物。
- 前記タウリンの微細針状結晶中に空間を有し、該空間中に有用成分が内包されていることを特徴とする、請求項1又は2に記載の皮膚外用剤組成物。
- 前記タウリンの微細針状結晶中の空間容積が、タウリン結晶体積中の0.001%~30%を占めることを特徴とする、請求項3に記載の皮膚外用剤組成物。
- 前記タウリンの微細針状結晶の太さが150マイクロメートル以下、長さが3000マイクロメートル以下である、請求項1~4のいずれか1項に記載の皮膚外用剤組成物。
- 前記有用成分が、ビタミン類及びビタミン誘導体、ハイドロキノン及びその誘導体、美白成分、抗炎症成分、抗酸化成分、血行促進成分、細胞賦活成分、補酵素及びその中間代謝物、糖類、植物抽出成分、ペプチド、タンパク質、並びに色素からなる群より選ばれる1種又は2種以上であることを特徴とする、請求項1~5のいずれか1項に記載の皮膚外用剤組成物。
- 前記タウリンの微細針状結晶中の前記有用成分の包含率が0.001%~30%であることを特徴とする、請求項1~6のいずれか1項に記載の皮膚外用剤組成物。
- さらに、皮膚外用剤組成物媒体中にも有用成分が溶解ないし分散している、請求項1~7のいずれか1項に記載の皮膚外用剤組成物。
- タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程を含み、ここで、該水溶液(A)中又は該液体物質(B)中に有用成分が溶解又は分散していることにより、該有用成分は、結晶成長に伴って該結晶に包含されることを特徴とする、結晶中に有用成分を包含するタウリンの微細針状結晶の製造方法。
- 前記液体物質(B)が水溶性有機溶媒であることを特徴とする、請求項9に記載の製造方法。
- 前記水溶性有機溶媒が、エタノール、イソプロピルアルコール、エチレングリコール、1,2-プロパンジオール、1,3-プロパンジオール、1,2-ブタンジオール、1,3-ブタンジオール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,2-ペンタンジオール、1,2-ヘキサンジオール、シクロヘキシルグリセリン、及びn-ヘキシルグリセリンからなる群より選ばれる1種又は2種以上であることを特徴とする、請求項10に記載の製造方法。
- 前記有用成分の濃度が、前記水溶液(A)中又は前記液体物質(B)中、0.001質量%以上であることを特徴とする、請求項9~11のいずれか1項に記載の製造方法。
- 前記水溶液(A)中のタウリンの濃度が3~28質量%であることを特徴とする、請求項9~12のいずれか1項に記載の製造方法。
- 前記液体物質(B)が、前記水溶液(A)の全量に対して50質量%以下であることを特徴とする、請求項9~13のいずれか1項に記載の製造方法。
- 結晶中に有用成分を包含するタウリンの微細針状結晶を含有する皮膚外用剤組成物の製造方法であって、下記工程:
タウリンが溶解した水溶液(A)を、タウリンの溶解性の低い液体物質(B)に混合、又は接触させた環境下で結晶成長させる工程、ここで、該水溶液(A)中又は該液体物質(B)中に有用成分が溶解又は分散していることにより、該有用成分は、結晶成長に伴って該結晶に包含される、及び、
前記結晶成長させる工程で得られた、結晶中に有用成分を包含するタウリンの微細針状結晶を皮膚外用剤組成物に配合する工程、
を含む、製造方法。 - 前記有用成分の濃度が、前記水溶液(A)中又は前記液体物質(B)中、0.001質量%以上であることを特徴とする、請求項15に記載の製造方法。
- 前記水溶液(A)中のタウリンの濃度が3~28質量%であることを特徴とする、請求項15又は16に記載の製造方法。
- 前記液体物質(B)が、前記水溶液(A)の全量に対して50質量%以下であることを特徴とする、請求項15~17のいずれか1項に記載の製造方法。
- 前記液体物質(B)が水溶性有機溶媒であり、
前記水溶性有機溶媒が、エタノール、イソプロピルアルコール、エチレングリコール、1,2-プロパンジオール、1,3-プロパンジオール、1,2-ブタンジオール、1,3-ブタンジオール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、1,2-ペンタンジオール、1,2-ヘキサンジオール、シクロヘキシルグリセリン、及びn-ヘキシルグリセリンからなる群より選ばれる1種又は2種以上であることを特徴とする、請求項15~18のいずれか1項に記載の製造方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202280038252.6A CN117460490A (zh) | 2022-04-25 | 2022-12-21 | 配合有包藏有用成分的牛磺酸晶体的皮肤外用剂组合物 |
US18/565,074 US20240197602A1 (en) | 2022-04-25 | 2022-12-21 | Dermatological topical agent composition containing useful component-including taurine crystals |
CA3226955A CA3226955A1 (en) | 2022-04-25 | 2022-12-21 | Dermatological topical agent composition containing useful component-including taurine crystals |
KR1020237040388A KR20240001707A (ko) | 2022-04-25 | 2022-12-21 | 유용 성분 포함 타우린 결정을 배합한 피부 외용제 조성물 |
AU2022456541A AU2022456541A1 (en) | 2022-04-25 | 2022-12-21 | Dermatological topical agent composition containing useful component-including taurine crystals |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022071711 | 2022-04-25 | ||
JP2022-071711 | 2022-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023210059A1 true WO2023210059A1 (ja) | 2023-11-02 |
Family
ID=87562930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/047061 WO2023210059A1 (ja) | 2022-04-25 | 2022-12-21 | 有用成分包含タウリン結晶を配合した皮膚外用剤組成物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20240197602A1 (ja) |
JP (2) | JP7327852B1 (ja) |
KR (1) | KR20240001707A (ja) |
CN (1) | CN117460490A (ja) |
AU (1) | AU2022456541A1 (ja) |
CA (1) | CA3226955A1 (ja) |
WO (1) | WO2023210059A1 (ja) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06192209A (ja) | 1992-12-25 | 1994-07-12 | Mitsui Toatsu Chem Inc | タウリンの精製法 |
JPH0717943A (ja) | 1993-07-02 | 1995-01-20 | Mitsui Toatsu Chem Inc | タウリンの精製法 |
JP2002536391A (ja) | 1999-02-12 | 2002-10-29 | ザ、プロクター、エンド、ギャンブル、カンパニー | 化粧品組成物 |
JP2004500392A (ja) | 2000-03-17 | 2004-01-08 | ビーエーエスエフ アクチェンゲゼルシャフト | 水溶性ビタミンの油性懸濁液の製造方法 |
JP2005232026A (ja) | 2004-02-17 | 2005-09-02 | Mitsui Chemicals Inc | タウリンの精製方法 |
JP2005325080A (ja) | 2004-05-17 | 2005-11-24 | Daiichi Fine Chemical Co Ltd | パントテン酸カルシウム及びビタミン類を含む組成物 |
WO2013054809A1 (ja) * | 2011-10-14 | 2013-04-18 | 大正製薬株式会社 | 皮膚外用剤 |
CN103848763A (zh) * | 2014-03-20 | 2014-06-11 | 天津大学 | 采用有机羧酸或有机羧酸盐添加剂改变牛磺酸晶体形态的方法 |
JP2016172725A (ja) * | 2015-03-16 | 2016-09-29 | 大正製薬株式会社 | タウリン含有組成物 |
WO2021043627A1 (en) * | 2019-09-06 | 2021-03-11 | Unilever Global Ip Limited | Microcapsule and hair care composition |
JP2021063060A (ja) | 2019-10-16 | 2021-04-22 | チェンジャン ヨンアン ファーマシュティカル カンパニー リミテッド | タウリン母液を全回収して処理する方法及び製造システム |
JP2021172652A (ja) | 2020-04-22 | 2021-11-01 | チェンジャン ヨンアン ファーマシュティカル カンパニー リミテッド | 高純度タウリン及び塩の調製方法、及びシステム |
-
2022
- 2022-12-21 JP JP2022204969A patent/JP7327852B1/ja active Active
- 2022-12-21 CN CN202280038252.6A patent/CN117460490A/zh active Pending
- 2022-12-21 AU AU2022456541A patent/AU2022456541A1/en active Pending
- 2022-12-21 CA CA3226955A patent/CA3226955A1/en active Pending
- 2022-12-21 KR KR1020237040388A patent/KR20240001707A/ko unknown
- 2022-12-21 US US18/565,074 patent/US20240197602A1/en active Pending
- 2022-12-21 WO PCT/JP2022/047061 patent/WO2023210059A1/ja active Application Filing
-
2023
- 2023-07-27 JP JP2023122902A patent/JP2023161590A/ja active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06192209A (ja) | 1992-12-25 | 1994-07-12 | Mitsui Toatsu Chem Inc | タウリンの精製法 |
JPH0717943A (ja) | 1993-07-02 | 1995-01-20 | Mitsui Toatsu Chem Inc | タウリンの精製法 |
JP2002536391A (ja) | 1999-02-12 | 2002-10-29 | ザ、プロクター、エンド、ギャンブル、カンパニー | 化粧品組成物 |
JP2004500392A (ja) | 2000-03-17 | 2004-01-08 | ビーエーエスエフ アクチェンゲゼルシャフト | 水溶性ビタミンの油性懸濁液の製造方法 |
JP2005232026A (ja) | 2004-02-17 | 2005-09-02 | Mitsui Chemicals Inc | タウリンの精製方法 |
JP2005325080A (ja) | 2004-05-17 | 2005-11-24 | Daiichi Fine Chemical Co Ltd | パントテン酸カルシウム及びビタミン類を含む組成物 |
WO2013054809A1 (ja) * | 2011-10-14 | 2013-04-18 | 大正製薬株式会社 | 皮膚外用剤 |
CN103848763A (zh) * | 2014-03-20 | 2014-06-11 | 天津大学 | 采用有机羧酸或有机羧酸盐添加剂改变牛磺酸晶体形态的方法 |
JP2016172725A (ja) * | 2015-03-16 | 2016-09-29 | 大正製薬株式会社 | タウリン含有組成物 |
WO2021043627A1 (en) * | 2019-09-06 | 2021-03-11 | Unilever Global Ip Limited | Microcapsule and hair care composition |
JP2021063060A (ja) | 2019-10-16 | 2021-04-22 | チェンジャン ヨンアン ファーマシュティカル カンパニー リミテッド | タウリン母液を全回収して処理する方法及び製造システム |
JP2021172652A (ja) | 2020-04-22 | 2021-11-01 | チェンジャン ヨンアン ファーマシュティカル カンパニー リミテッド | 高純度タウリン及び塩の調製方法、及びシステム |
Also Published As
Publication number | Publication date |
---|---|
JP2023161590A (ja) | 2023-11-07 |
US20240197602A1 (en) | 2024-06-20 |
KR20240001707A (ko) | 2024-01-03 |
CN117460490A (zh) | 2024-01-26 |
JP7327852B1 (ja) | 2023-08-16 |
JP2023161549A (ja) | 2023-11-07 |
CA3226955A1 (en) | 2023-11-02 |
AU2022456541A1 (en) | 2023-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5007471B2 (ja) | 機能性粉体 | |
JP5613546B2 (ja) | 外用組成物及びその製造方法 | |
JP2000119156A (ja) | 皮膚外用剤 | |
JP3926711B2 (ja) | 表皮の偏平化を予防、防止、改善する皮膚老化防止用組成物 | |
JP2006028148A (ja) | 外用組成物 | |
JP2001031558A (ja) | 皮膚外用剤 | |
JP3987793B2 (ja) | 皮膚外用剤 | |
JPH04182412A (ja) | 皮膚外用剤 | |
JP2002212087A (ja) | 皮膚外用剤 | |
JP2007161681A (ja) | しわ防止および皮膚状態改善剤 | |
WO2023210059A1 (ja) | 有用成分包含タウリン結晶を配合した皮膚外用剤組成物 | |
KR20130097148A (ko) | 트라넥사메이트의 생리학적으로 허용 가능한 염을 함유하는 외용 조성물의 제조방법 | |
JP2009242344A (ja) | ケラチノサイト増殖促進剤 | |
WO2023199995A1 (ja) | タウリンの微細針状又は柱状結晶を配合した皮膚外用剤組成物 | |
WO2023127882A1 (ja) | スキンケア用皮膚適用組成物 | |
JP2002275081A (ja) | 皮膚外用剤 | |
JP2005336156A (ja) | アスコルビン酸誘導体塩を含む皮膚外用剤、該皮膚外用剤の安定化方法および安定化剤 | |
JP5398129B2 (ja) | 肌新陳代謝促進剤 | |
JPWO2006011633A1 (ja) | 皮膚メラニン抑制剤 | |
JP3746260B2 (ja) | 皮膚外用剤 | |
JP2009256326A (ja) | 美白剤、及び皮膚外用剤 | |
JP2005220085A (ja) | 老化防止剤、並びにそれを用いた皮膚外用剤及び細胞賦活方法 | |
JP2002284630A (ja) | 皮膚外用剤及び皮膚外用剤組成物 | |
JP5291369B2 (ja) | ケラチノサイト増殖促進剤 | |
JPH11269028A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 20237040388 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020237040388 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280038252.6 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18565074 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022456541 Country of ref document: AU Ref document number: AU2022456541 Country of ref document: AU |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22940328 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022456541 Country of ref document: AU Date of ref document: 20221221 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3226955 Country of ref document: CA |